EP4358719A1 - Fluid delivery device - Google Patents
Fluid delivery deviceInfo
- Publication number
- EP4358719A1 EP4358719A1 EP22826873.6A EP22826873A EP4358719A1 EP 4358719 A1 EP4358719 A1 EP 4358719A1 EP 22826873 A EP22826873 A EP 22826873A EP 4358719 A1 EP4358719 A1 EP 4358719A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- solution
- formulation
- stabilised
- double
- variable volume
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000012530 fluid Substances 0.000 title description 61
- 239000000203 mixture Substances 0.000 claims abstract description 69
- 238000009472 formulation Methods 0.000 claims abstract description 57
- 229920000139 polyethylene terephthalate Polymers 0.000 claims abstract description 38
- 239000005020 polyethylene terephthalate Substances 0.000 claims abstract description 38
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical group O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 claims abstract description 32
- -1 polyethylene terephthalate Polymers 0.000 claims abstract description 32
- 238000004806 packaging method and process Methods 0.000 claims abstract description 29
- 239000003380 propellant Substances 0.000 claims abstract description 21
- 229910002092 carbon dioxide Inorganic materials 0.000 claims abstract description 16
- 239000001569 carbon dioxide Substances 0.000 claims abstract description 13
- 238000003825 pressing Methods 0.000 claims abstract description 8
- 230000000845 anti-microbial effect Effects 0.000 claims abstract description 5
- 239000004599 antimicrobial Substances 0.000 claims abstract description 4
- 239000002253 acid Substances 0.000 claims description 33
- 238000000034 method Methods 0.000 claims description 32
- QWPPOHNGKGFGJK-UHFFFAOYSA-N hypochlorous acid Chemical compound ClO QWPPOHNGKGFGJK-UHFFFAOYSA-N 0.000 claims description 25
- 238000011282 treatment Methods 0.000 claims description 18
- 230000000249 desinfective effect Effects 0.000 claims description 15
- 235000013305 food Nutrition 0.000 claims description 14
- 239000000499 gel Substances 0.000 claims description 11
- 238000005868 electrolysis reaction Methods 0.000 claims description 8
- 239000000463 material Substances 0.000 claims description 8
- 239000000017 hydrogel Substances 0.000 claims description 7
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 4
- 239000000919 ceramic Substances 0.000 claims description 4
- 239000006260 foam Substances 0.000 claims description 4
- 239000006071 cream Substances 0.000 claims description 3
- 150000004820 halides Chemical class 0.000 claims description 3
- 239000007921 spray Substances 0.000 claims description 3
- 238000004659 sterilization and disinfection Methods 0.000 claims description 3
- 206010012438 Dermatitis atopic Diseases 0.000 claims description 2
- 229910000831 Steel Inorganic materials 0.000 claims description 2
- 201000008937 atopic dermatitis Diseases 0.000 claims description 2
- 239000011521 glass Substances 0.000 claims description 2
- 229910052742 iron Inorganic materials 0.000 claims description 2
- 239000003595 mist Substances 0.000 claims description 2
- 229910052573 porcelain Inorganic materials 0.000 claims description 2
- 208000017520 skin disease Diseases 0.000 claims description 2
- 239000010959 steel Substances 0.000 claims description 2
- 241000124008 Mammalia Species 0.000 claims 2
- 229940104869 fluorosilicate Drugs 0.000 claims 1
- 239000003897 fog Substances 0.000 claims 1
- 239000007788 liquid Substances 0.000 abstract description 20
- 230000009974 thixotropic effect Effects 0.000 abstract description 4
- 239000000243 solution Substances 0.000 description 131
- 239000007789 gas Substances 0.000 description 38
- 206010052428 Wound Diseases 0.000 description 30
- 208000027418 Wounds and injury Diseases 0.000 description 30
- 239000000047 product Substances 0.000 description 27
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical class OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 14
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 14
- 210000001519 tissue Anatomy 0.000 description 14
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 12
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 12
- 239000000460 chlorine Substances 0.000 description 12
- 229910052801 chlorine Inorganic materials 0.000 description 12
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 11
- 239000000443 aerosol Substances 0.000 description 11
- 239000004411 aluminium Substances 0.000 description 11
- 229910052782 aluminium Inorganic materials 0.000 description 11
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 11
- 239000000126 substance Substances 0.000 description 11
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical class [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 10
- 210000004027 cell Anatomy 0.000 description 9
- 230000007935 neutral effect Effects 0.000 description 9
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 8
- 239000002537 cosmetic Substances 0.000 description 8
- 238000011049 filling Methods 0.000 description 7
- 239000011780 sodium chloride Substances 0.000 description 7
- 230000009471 action Effects 0.000 description 6
- 230000004888 barrier function Effects 0.000 description 6
- WQYVRQLZKVEZGA-UHFFFAOYSA-N hypochlorite Chemical compound Cl[O-] WQYVRQLZKVEZGA-UHFFFAOYSA-N 0.000 description 6
- 150000003839 salts Chemical class 0.000 description 6
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 5
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 5
- 150000001342 alkaline earth metals Chemical class 0.000 description 5
- 239000007864 aqueous solution Substances 0.000 description 5
- 229910052799 carbon Inorganic materials 0.000 description 5
- 230000008859 change Effects 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 5
- 244000005700 microbiome Species 0.000 description 5
- 229920000642 polymer Polymers 0.000 description 5
- 230000003019 stabilising effect Effects 0.000 description 5
- 238000003860 storage Methods 0.000 description 5
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 4
- 239000004677 Nylon Substances 0.000 description 4
- 239000003513 alkali Substances 0.000 description 4
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 4
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 4
- 238000004140 cleaning Methods 0.000 description 4
- 230000006866 deterioration Effects 0.000 description 4
- 239000003792 electrolyte Substances 0.000 description 4
- 238000001802 infusion Methods 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 229910052757 nitrogen Inorganic materials 0.000 description 4
- 229920001778 nylon Polymers 0.000 description 4
- 241000894007 species Species 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 229920000219 Ethylene vinyl alcohol Polymers 0.000 description 3
- 241000233866 Fungi Species 0.000 description 3
- 230000004913 activation Effects 0.000 description 3
- 210000004666 bacterial spore Anatomy 0.000 description 3
- 230000003115 biocidal effect Effects 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 235000013399 edible fruits Nutrition 0.000 description 3
- 239000004715 ethylene vinyl alcohol Substances 0.000 description 3
- 239000003102 growth factor Substances 0.000 description 3
- 238000012417 linear regression Methods 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 235000011007 phosphoric acid Nutrition 0.000 description 3
- 229910052700 potassium Inorganic materials 0.000 description 3
- 239000011591 potassium Substances 0.000 description 3
- 210000004215 spore Anatomy 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 229920001169 thermoplastic Polymers 0.000 description 3
- 239000005028 tinplate Substances 0.000 description 3
- 235000013311 vegetables Nutrition 0.000 description 3
- 241000193830 Bacillus <bacterium> Species 0.000 description 2
- 241000193755 Bacillus cereus Species 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 2
- 239000004698 Polyethylene Substances 0.000 description 2
- 239000004743 Polypropylene Substances 0.000 description 2
- 239000004793 Polystyrene Substances 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
- 239000005708 Sodium hypochlorite Substances 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 239000003570 air Substances 0.000 description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
- 229910052786 argon Inorganic materials 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 235000013405 beer Nutrition 0.000 description 2
- 239000004568 cement Substances 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 238000002788 crimping Methods 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 239000000645 desinfectant Substances 0.000 description 2
- 229910001873 dinitrogen Inorganic materials 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- UFRKOOWSQGXVKV-UHFFFAOYSA-N ethene;ethenol Chemical compound C=C.OC=C UFRKOOWSQGXVKV-UHFFFAOYSA-N 0.000 description 2
- 230000007760 free radical scavenging Effects 0.000 description 2
- 230000002538 fungal effect Effects 0.000 description 2
- 210000003128 head Anatomy 0.000 description 2
- 230000000415 inactivating effect Effects 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 238000007726 management method Methods 0.000 description 2
- 229910017604 nitric acid Inorganic materials 0.000 description 2
- 231100000344 non-irritating Toxicity 0.000 description 2
- 238000001139 pH measurement Methods 0.000 description 2
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 description 2
- 239000012466 permeate Substances 0.000 description 2
- 229920000573 polyethylene Polymers 0.000 description 2
- 229920001155 polypropylene Polymers 0.000 description 2
- 229920002223 polystyrene Polymers 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 description 2
- 235000014214 soft drink Nutrition 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 235000011149 sulphuric acid Nutrition 0.000 description 2
- 230000007704 transition Effects 0.000 description 2
- 239000012780 transparent material Substances 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 238000012371 Aseptic Filling Methods 0.000 description 1
- 241000193738 Bacillus anthracis Species 0.000 description 1
- 241000194106 Bacillus mycoides Species 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 241000193388 Bacillus thuringiensis Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 1
- 241000193163 Clostridioides difficile Species 0.000 description 1
- 206010011985 Decubitus ulcer Diseases 0.000 description 1
- 206010048768 Dermatosis Diseases 0.000 description 1
- 206010056340 Diabetic ulcer Diseases 0.000 description 1
- 241000002314 Dichotomopilus funicola Species 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000194033 Enterococcus Species 0.000 description 1
- 101710146739 Enterotoxin Proteins 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 206010063560 Excessive granulation tissue Diseases 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 229920000007 Nylon MXD6 Polymers 0.000 description 1
- BPQQTUXANYXVAA-UHFFFAOYSA-N Orthosilicate Chemical compound [O-][Si]([O-])([O-])[O-] BPQQTUXANYXVAA-UHFFFAOYSA-N 0.000 description 1
- 208000004210 Pressure Ulcer Diseases 0.000 description 1
- 201000004681 Psoriasis Diseases 0.000 description 1
- 241001303601 Rosacea Species 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 208000002847 Surgical Wound Diseases 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- 208000000558 Varicose Ulcer Diseases 0.000 description 1
- 238000005299 abrasion Methods 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 229940065181 bacillus anthracis Drugs 0.000 description 1
- 229940097012 bacillus thuringiensis Drugs 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 239000011449 brick Substances 0.000 description 1
- 239000001273 butane Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 239000011111 cardboard Substances 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- XTEGARKTQYYJKE-UHFFFAOYSA-N chloric acid Chemical compound OCl(=O)=O XTEGARKTQYYJKE-UHFFFAOYSA-N 0.000 description 1
- 229940005991 chloric acid Drugs 0.000 description 1
- 238000005660 chlorination reaction Methods 0.000 description 1
- 230000002759 chromosomal effect Effects 0.000 description 1
- 239000004927 clay Substances 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000001804 debridement Methods 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 238000010494 dissociation reaction Methods 0.000 description 1
- 230000005593 dissociations Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000013013 elastic material Substances 0.000 description 1
- 239000000147 enterotoxin Substances 0.000 description 1
- 231100000655 enterotoxin Toxicity 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 238000013213 extrapolation Methods 0.000 description 1
- 210000000416 exudates and transudate Anatomy 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 238000009408 flooring Methods 0.000 description 1
- NBVXSUQYWXRMNV-UHFFFAOYSA-N fluoromethane Chemical compound FC NBVXSUQYWXRMNV-UHFFFAOYSA-N 0.000 description 1
- 244000053095 fungal pathogen Species 0.000 description 1
- 230000002070 germicidal effect Effects 0.000 description 1
- 210000001126 granulation tissue Anatomy 0.000 description 1
- 239000011440 grout Substances 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 231100001261 hazardous Toxicity 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- RZXDTJIXPSCHCI-UHFFFAOYSA-N hexa-1,5-diene-2,5-diol Chemical compound OC(=C)CCC(O)=C RZXDTJIXPSCHCI-UHFFFAOYSA-N 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 1
- CUILPNURFADTPE-UHFFFAOYSA-N hypobromous acid Chemical compound BrO CUILPNURFADTPE-UHFFFAOYSA-N 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 239000002648 laminated material Substances 0.000 description 1
- 230000001050 lubricating effect Effects 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 231100000243 mutagenic effect Toxicity 0.000 description 1
- 230000003505 mutagenic effect Effects 0.000 description 1
- IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 1
- OFBQJSOFQDEBGM-UHFFFAOYSA-N n-pentane Natural products CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 1
- 210000003928 nasal cavity Anatomy 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 238000009581 negative-pressure wound therapy Methods 0.000 description 1
- JCXJVPUVTGWSNB-UHFFFAOYSA-N nitrogen dioxide Inorganic materials O=[N]=O JCXJVPUVTGWSNB-UHFFFAOYSA-N 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 230000020477 pH reduction Effects 0.000 description 1
- 239000000123 paper Substances 0.000 description 1
- 239000011087 paperboard Substances 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 239000011505 plaster Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 239000011112 polyethylene naphthalate Substances 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 238000005086 pumping Methods 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 201000004700 rosacea Diseases 0.000 description 1
- 239000013535 sea water Substances 0.000 description 1
- 230000001235 sensitizing effect Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229940104870 sodium magnesium fluorosilicate Drugs 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 238000012430 stability testing Methods 0.000 description 1
- 210000000130 stem cell Anatomy 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 239000001117 sulphuric acid Substances 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 239000004416 thermosoftening plastic Substances 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 239000012049 topical pharmaceutical composition Substances 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- AZJYLVAUMGUUBL-UHFFFAOYSA-A u1qj22mc8e Chemical compound [F-].[F-].[F-].[F-].[F-].[F-].[F-].[F-].[F-].[F-].[F-].[F-].[F-].[F-].[F-].[F-].[F-].[F-].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].O=[Si]=O.O=[Si]=O.O=[Si]=O.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3 AZJYLVAUMGUUBL-UHFFFAOYSA-A 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 244000052613 viral pathogen Species 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/16—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using chemical substances
- A61L2/18—Liquid substances or solutions comprising solids or dissolved gases
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N59/00—Biocides, pest repellants or attractants, or plant growth regulators containing elements or inorganic compounds
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01P—BIOCIDAL, PEST REPELLANT, PEST ATTRACTANT OR PLANT GROWTH REGULATORY ACTIVITY OF CHEMICAL COMPOUNDS OR PREPARATIONS
- A01P1/00—Disinfectants; Antimicrobial compounds or mixtures thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23B—PRESERVING, e.g. BY CANNING, MEAT, FISH, EGGS, FRUIT, VEGETABLES, EDIBLE SEEDS; CHEMICAL RIPENING OF FRUIT OR VEGETABLES; THE PRESERVED, RIPENED, OR CANNED PRODUCTS
- A23B7/00—Preservation or chemical ripening of fruit or vegetables
- A23B7/14—Preserving or ripening with chemicals not covered by groups A23B7/08 or A23B7/10
- A23B7/153—Preserving or ripening with chemicals not covered by groups A23B7/08 or A23B7/10 in the form of liquids or solids
- A23B7/157—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L3/00—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs
- A23L3/34—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals
- A23L3/3454—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals in the form of liquids or solids
- A23L3/358—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/20—Elemental chlorine; Inorganic compounds releasing chlorine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
- A61L2/0082—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using chemical substances
- A61L2/0088—Liquid substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D83/00—Containers or packages with special means for dispensing contents
- B65D83/14—Containers or packages with special means for dispensing contents for delivery of liquid or semi-liquid contents by internal gaseous pressure, i.e. aerosol containers comprising propellant for a product delivered by a propellant
- B65D83/60—Contents and propellant separated
- B65D83/62—Contents and propellant separated by membrane, bag, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2101/00—Chemical composition of materials used in disinfecting, sterilising or deodorising
- A61L2101/02—Inorganic materials
- A61L2101/06—Inorganic materials containing halogen
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D83/00—Containers or packages with special means for dispensing contents
- B65D83/14—Containers or packages with special means for dispensing contents for delivery of liquid or semi-liquid contents by internal gaseous pressure, i.e. aerosol containers comprising propellant for a product delivered by a propellant
- B65D83/60—Contents and propellant separated
- B65D83/62—Contents and propellant separated by membrane, bag, or the like
- B65D83/625—Contents and propellant separated by membrane, bag, or the like the propellant being generated by a chemical or electrochemical reaction
Definitions
- the present invention relates to a stabilised solution or formulation of hypohalous acid, such as hypochlorous acid (HOCI), packaged in a double-compartment packaging of the type used to deliver fluids under pressure. More specifically, the invention relates to a stabilised solution or formulation of hypohalous acid packaged in a non-aspirating dispenser that comprises a pressure-resisting external container having a flexible container of variable volume therein enclosing the stabilised solutions or formulations (a liquid or a thixotropic gel), and comprising a pressurised gas that is capable of exerting pressure on said flexible container of variable volume and forcing said stabilised solutions or formulations out of said flexible container of variable volume in a steady stream upon pressing an actuator that is operatively connected to an ejection valve.
- hypohalous acid such as hypochlorous acid (HOCI)
- HOCI hypochlorous acid
- the flexible container of variable volume is free of propellants and does not produce an aerosol.
- the actuator By pressing the actuator, the user can dispense the liquid or gel to a desired surface, in the form of droplets that are free of air or a gas therein.
- the invention finds use for cleaning and/or disinfecting surfaces, food such as fruit, vegetables, crops, cut flowers or mammalian tissues (including wounds).
- Typical spray bottles or containers dispense liquids or foams via a mechanical trigger that requires continual pumping thereof to dispense a sprayed product. Since very small amounts of product are dispensed with each pump, numerous pumps are required to adequately cover a surface. The same often exhausts the user and becomes an ergonomic issue as spraying numerous surfaces, articles, etc., may require a person to take a break or rest.
- dispensers such as a spray bottle, eject a fluid via aspiration such that an aerosol mist is formed.
- these dispensers are undesirable in sterile situations as the air drawn in by the aspirator may come from a contaminated environment.
- the aerosol droplets are small and therefore subject to being transported to an adjacent sterile environment and contaminating the same.
- dispensers contain a sprayable liquid in association with propellants such as volatile hydrocarbons, e.g. butane, propane, or fluorocarbon gases that can pose flammable or toxic problems.
- propellants such as volatile hydrocarbons, e.g. butane, propane, or fluorocarbon gases that can pose flammable or toxic problems.
- the liquid or gel to be dispensed cannot be put in contact with the propellant, as the two fluids are not chemically compatible.
- U.S. Patents No. 4,387,833, 4,423,829, 5,927,551 and 4,964,540 describe devices that can be operated in all positions and also in the inverted position. With them the fluid is delivered, not by the action of a propellant gas, but under the action of a mechanical constraint, which is exerted on a container that has the shape of a pouch or flexible receptacle of variable volume; this container generally has a cylindrical shape, is equipped with longitudinal pleats, and is filled with the fluid to be delivered.
- the mechanical constraint under the action of which the liquid contained within the container of variable volume is delivered under pressure, is exerted by a cylindrical sleeve of elastic material, especially rubber with particular elastic properties, which envelops the container in the form of a pouch or flexible receptacle and whose diameter is slightly larger than the diameter of the container of variable volume when the latter is empty.
- the sleeve in question is then put into place and the fluid to be delivered is introduced under pressure into the container which expands against the opposite action of the elastic sleeve of which the compression force exerted on the container increases with the expansion of said container due to the filling with the fluid to be delivered.
- the container in the form of a pouch or flexible receptacle is equipped with an actuator that allows the activation of a valve for the delivery of the fluid, the whole being arranged inside a classic container or reservoir of the type used in the aerosol industry, notably in cosmetics or personal care products.
- a flexible container of variable volume intended to be filled with the fluid to be delivered, and also equipped with an actuator adapted to activate a valve to permit the fluid under pressure to be delivered, is located inside an external container capable of resisting elevated pressures, notably in excess of 20 bars; this pressure-resisting external container is filled with a neutral gas under pressure, the empty flexible container of variable volume being in place and then the latter is filled with the fluid to be delivered, this fluid being introduced under a pressure which is sufficient to overcome the pressure exerted on the container by the neutral gas with which the pressure-resisting external container is filled, which consequently further increases the pressure of the neutral gas.
- U.S. Patent Application 2008/0272145 discloses a device that comprises a container of variable volume in the form or shape of a pouch or flexible receptacle of generally cylindrical shape with longitudinal pleats containing the fluid under pressure to be delivered and equipped with an actuator permitting to open a valve to enable the aforementioned fluid to be delivered, the whole being located inside an external container capable of resisting an elevated internal pressure which is notably superior to 20 bars, the internal volume of the latter container comprises, between its wall and the container of variable volume being filled with the fluid to be delivered, a neutral gas under a pressure sufficient to exert on the container of variable volume a pneumatic constraint sufficient to allow the delivery of the therein contained fluid when the aforementioned valve permitting said delivery is operated by the aforementioned actuator.
- the container of variable volume containing the fluid to be delivered and the external pressure-resisting container are both made of transparent materials (e.g. polyethylene terephthalate or PET), allowing the user to see the fluid and to determine at every moment the state of filling of the device as well as any alteration of the fluid which could lead to a change in the aspect of the same (colouring, separation of phases, etc.).
- transparent materials e.g. polyethylene terephthalate or PET
- the container of variable volume containing the fluid to be delivered and the external pressure-resisting container may be realised using laminated materials wherein at least one of the constitutive layers confers to the laminate sufficient mechanical resistance, while another layer may confer the properties of a barrier to gas, in particular to oxygen, nitrogen and/or carbon dioxide, and/or while another layer may still confer the properties of chemical resistance to the product to be delivered.
- a layer adapted to confer good mechanical resistance may, for example, be constituted of polyethylene terephthalate or PET.
- a layer adapted to confer good gas barrier properties may, for example, be realized in Nylon, especially Nylon MXD6, or in ethylene vinyl alcohol resin (or EVOH).
- a layer adapted to confer good properties of chemical resistance may also, for example, be constituted in polyethylene terephthalate.
- the container of variable volume containing the fluid to be delivered may be constituted either by using a laminate of the type PET/Nylon/PET, that is to say comprising an external layer of polyethylene terephthalate, an intermediate layer of Nylon and an internal layer, that is to say a layer intended to be in contact with the fluid to be delivered, also of polyethylene terephthalate; or by using a laminate of the type PET/EVOH/PET.
- the pressure-resisting external container may be advantageously realised in the same material.
- the material constituting this container is not in contact with the fluid to be delivered, it is possible to use a bi-layer laminate, for example in polyethylene terephthalate and Nylon.
- a material of this type which does not comprise an internal layer conferring chemical resistance, may also be employed for the constitution of the container of variable volume containing the fluid to be delivered, provided that the fluid to be delivered is chemically compatible with the other layers.
- a method for producing a device for dispensing fluid product under pressure, an apparatus for implementing the production method, and a device for dispensing a pressurised fluid product comprises: a valve equipped with a stem, being suitable for dispensing the pressurised fluid product to outside when the stem is in the actuation position; an internal reservoir with a variable volume, a deformable side wall and a dispensing opening; an external container, made of thermoplastic rigid polymer; an attachment sleeve made of thermoplastic polymer, sealingly attached to the internal reservoir, and also welded to the external container.
- the internal reservoir and the valve are placed in the external container so that the axis A of the internal reservoir and the axis B of the external container are coaxial.
- the external container and the internal reservoir then delimit between them an internal volume in which a pressurised gas is placed.
- the gas may be at least one of, or a mixture of, the gases selected from the group air, nitrogen, argon, carbon dioxide or another gas. Provision is made for the external container to form a barrier to the gas and to offer a chemical resistance to the gas and a mechanical resistance to a pressure higher than 20 bar.
- the external container is made of thermoplastic polymer, such as polyethylene terephthalate (PET) or polyethylene naphthalate (PEN), advantageously transparent, used alone or in the form of a mixture, in order to be able to soften under the action of heat and harden when cooling, in order to form a barrier to the gas and to offer the chemical resistance and mechanical resistance to pressure.
- thermoplastic polymer such as polyethylene terephthalate (PET) or polyethylene naphthalate (PEN), advantageously transparent, used alone or in the form of a mixture, in order to be able to soften under the action of heat and harden when cooling, in order to form a barrier to the gas and to offer the chemical resistance and mechanical resistance to pressure.
- PET polyethylene terephthalate
- PET polyethylene terephthalate
- PET is known to exhibit very low gas permeation compared with most polymers such as polystyrene, polyethylene and polypropylene (Fernandez-Menendez et al., Polymer Testing 90 (2020) 106729); in addition, PET bottles are widely used as containers for carbonated liquids (e.g. carbonated water, soft drinks, beer, etc.).
- WO 2012/129161 is also in support to the above, as it discloses a stabilised solution or formulation packaged in a container for storage or sale, comprising hypochlorous acid and a stabilising amount of dissolved inorganic carbon (DIC) incorporated in the form of a bicarbonate or carbonate of an alkali or alkaline earth metal, wherein the solution or formulation has an available free chlorine (AFC) content of from about 10 to about 10,000 parts per million, a pH of from about 4.0 to 7.0, a DIC-to-AFC molar ratio of from 5:1 to 1 :5, and wherein the container is minimally permeable to CO2 or O2.
- AFC available free chlorine
- Figure 6 in WO 2012/129161 shows the results of an extended stability study of HOCI produced by electrochemical treatment of a NaHCOs-enriched NaCI solution at pH 5.4, bottled in a polyethylene terephthalate (PET) container and stored at room temperature.
- PET polyethylene terephthalate
- the method disclosed in WO 2012/129161 for obtaining the stabilised solution or formulation involves incorporating the DIC (e.g., in the form of carbonate or bicarbonate) by adding it to an electrolyte for electrochemical treatment, or incorporating the DIC (e.g., in the form of carbonate or bicarbonate) by directly adding it to an electrolysed solution comprising hypohalous acid (e.g., HOCI). More in detail, WO 2012/129161 teaches that the stabilised hypochlorous acid solutions (e.g., solutions of greater than 90%, 95%, or 97% HOCI) may be obtained by electrolysis of a saline solution as described in U.S.
- hypohalous acid e.g., HOCI
- Patent 7,276,255 can be prepared by any suitable method or apparatus by incorporating the bicarbonate or carbonate into the dry electrolyte or the solution for electrolysis.
- the carbonate or bicarbonate can be added to the dry electrolyte in accordance with the desired AFC content of the resulting solution.
- Hypochlorous acid solutions may be prepared by passing saline solution containing the carbonate/bicarbonate over coated titanium electrodes separated by a semi-permeable ceramic membrane at a current of about 6 to 9 Amps. Electrochemical treatment of saline is described, for example, in U.S. Patent 7,303,660, U.S. Patent 7,828,942, and U.S. Patent 7,897,023.
- the bicarbonates or carbonates are added prior to the formation of hypohalous acid (e.g., prior to the electrochemical treatment), and in other embodiments, the bicarbonates or carbonates are added to the solution after formation of hypohalous acid.
- the bicarbonate(s) or carbonate(s) may be added to the precursor solution, the electrolyte, and/or the end solution.
- a bicarbonate or carbonate of an alkali or alkaline earth metal When dissolved in water, a bicarbonate or carbonate of an alkali or alkaline earth metal imparts an alkaline pH to the solution.
- DIC dissolved inorganic carbon
- a particular electrolysis apparatus comprising one or more electrolytic cells, each of which comprises an anode, a cathode and a separator (diaphragm or membrane) capable of avoiding mixing between the solution treated at the anode and the one treated at the cathode.
- the saline solution i.e., a solution containing an alkali or alkaline earth halogenide
- the electrolytic treatment on the anode side of the electrolytic cell above described may allow to lower the solution pH up to acidic values (i.e. lower than 7), and thus to obtain a solution or formulation with the characteristics described by Panicheva et al. (WO 2012/129161).
- this can only be obtained by using an electrolysis apparatus in which the anode and cathode compartments are kept separated by using a diaphragm or a membrane.
- the present invention relates to a stabilised hypohalous acid solution or formulation thereof, conveniently packaged for sale in a double-compartment packaging of the type used to deliver fluids under pressure.
- the invention further relates to methods of use for disinfecting mammalian tissue, including wounds and burns, disinfecting or cleansing hard surfaces, treating (e.g., preserving and/or disinfecting) food products or cut flowers, among other uses.
- the invention relates to a stabilised solution or formulation of hypohalous acid packaged in a non-aspirating dispenser that comprises a pressure- resisting external container having a flexible container of variable volume therein enclosing the stabilised solution or formulation (a liquid or a thixotropic gel), and comprising a pressurised gas that is capable of exerting pressure on said flexible container of variable volume and forcing said stabilised solution or formulation out of said flexible container of variable volume in a steady stream upon pressing an actuator that is operatively connected to an ejection valve.
- the flexible container of variable volume is free of propellants and does not produce an aerosol.
- the user can dispense the liquid or gel to a desired surface, in the form of droplets that are free of air or a gas therein.
- the invention finds use for cleaning and/or disinfecting surfaces, food such as fruit, vegetables, crops, cut flowers or mammalian tissues (including wounds).
- the invention provides a stabilised solution or formulation comprising an antimicrobial solution, for example hypochlorous acid, wherein the solution or formulation has an available free chlorine (AFC) content of from about 10 to about 10,000 parts per million, a pH of from about 3.0 to 7.0, and is packaged in a double compartment packaging of the type used to deliver fluids under pressure.
- AFC available free chlorine
- the flexible container of variable volume containing the fluid to be delivered is in the form or shape of a pouch or flexible receptacle and is equipped with an actuator that allows the activation of a valve for the delivery of the fluid, the whole being located inside a pressure-resisting external container or reservoir of the type used in the aerosol industry, notably in cosmetics or personal care products.
- the internal volume of the pressure-resisting external container comprises, between its wall and the flexible container of variable volume being filled with the fluid to be delivered, a neutral gas under a pressure sufficient to exert on the flexible container of variable volume a pneumatic constraint sufficient to allow the delivery of the therein contained fluid when the aforementioned valve permitting said delivery is operated by the aforementioned actuator.
- the present invention provides a method for disinfecting or treating a mammalian tissue, the method comprising applying the solution or formulation to a mammalian tissue in need of disinfection or treatment.
- the present invention provides a method for disinfecting or cleansing a hard surface comprising applying the solution or formulation according to the first aspect of the invention to the hard surface, and optionally, wherein the hard surface comprises porcelain, glass, steel, iron, ceramic or polymeric material.
- the present invention provides a method of treating a food product comprising applying the solution or formulation according to the first aspect of the invention to the food product.
- the solution may have an available free chlorine (AFC) content of from about 10 to about 10,000 parts per million, and a pH of from about 3.0 to about 7.0.
- AFC available free chlorine
- the solution has a pH of from about 6.1 to about 6.75.
- the solution contains hypochlorous acid, and is prepared by electrolysis of saline.
- the solution is stabilised, as determined by its limited change in pH and/or AFC over time, for at least one month, but in various embodiments, the solution is stabilised for at least six months, at least one year, or more.
- the solution comprises HOCI produced by electrolysis of saline, and the solution may have an AFC content of from about 100 to about 500 parts per million, a pH in the range of about 3.0 to about 7.0, and a salinity of from about 0.02% to about 1.0%.
- the HOCI solution is formulated as a hydrogel.
- Also disclosed herein is a method for preparing a stabilised hypohalous acid solution packaged in a double-compartment packaging of the type used to deliver fluids under pressure.
- the method involves assembling a device of the type used in the aerosol industry, notably in cosmetics or personal care products; in particular, the device is a double-compartment packaging.
- a device of the type used in the aerosol industry notably in cosmetics or personal care products; in particular, the device is a double-compartment packaging.
- an aluminium or tinplate can pressure-resisting external container
- a valve on which a flexible container of variable volume (e.g., a multilayer film bag) and containing the product to be dispensed is affixed or welded.
- the propellant liquid or compressed gas
- the propellant is contained inside the pressure-resisting external container and outside the flexible container of variable volume, and squeezes the flexible container of variable volume to release the product through the valve.
- Figure 1 schematises the assembly procedure for a device of the type used in the aerosol industry, notably in cosmetics or personal care products; in particular, the device is a double-compartment packaging.
- the assembly procedure involves several steps: 1A placing a bag with affixed valve inside a container, 1B gassing (air/nitrogen) followed by crimping of the valve into the container, 1C filling the product into the bag, 1 D positioning of actuator and cap.
- Figure 2 shows the relative percentage of the HOCI and NaOCI species present in a free chlorine aqueous solution at a temperature of 20 °C and 0.1 M ionic strength, as a function of pH (Dissociation of hypochlorous acid, in White’s Handbook of Chlorination and Alternative Disinfectants (5 th edition), Black & Veatch Corporation, 2010).
- Figures 3A and 3B show the change in AFC and pH over storage time of packaged aqueous solutions of free chlorine (produced by electrochemical treatment of a NaCI solution), whose pH was initially adjusted to about 7 with hydrochloric acid; different double-compartment packaging of the type used to deliver fluids under pressure were filled with aliquots of the same solution, stored at 40°C to accelerate the deterioration of the solution, and kept unopened until measurement.
- Aluminium cans and flexible PET pouches equipped with a valve and an aluminium mounting cap were used; nitrogen gas was used as the propellant.
- the data shown are averages of three values; also shown is the linear regression (solid line) with 95% prediction intervals (broken lines).
- Figures 4A and 4B show the change in AFC and pH over storage time of packaged aqueous solutions of free chlorine (produced by electrochemical treatment of a NaCI solution), whose pH was initially adjusted to about 7 with hydrochloric acid; different double-compartment packaging of the type used to deliver fluids under pressure were filled with aliquots of the same solution, stored at 40°C to accelerate the deterioration of the solution, and kept unopened until measurement.
- Aluminium cans and flexible PET pouches equipped with a valve and an aluminium mounting cap were used; however, this time gaseous carbon dioxide was used as the propellant.
- the data shown are averages of three values, along with the non-linear regression (solid line) with 95% prediction intervals (broken lines).
- the present invention relates to a stabilised solution or formulation of hypohalous acid packaged in a non-aspirating dispenser that comprises a pressure-resisting external container having a flexible container of variable volume therein enclosing the stabilised solution or formulation (a liquid or a thixotropic gel), and comprising a pressurised gas that is capable of exerting pressure on said flexible container of variable volume and forcing said stabilised solution or formulation out of said flexible container of variable volume in a steady stream upon pressing an actuator that is operatively connected to an ejection valve.
- the flexible container of variable volume is free of propellants and does not produce an aerosol.
- the user can dispense the liquid or gel to a desired surface, in the form of droplets that are free of air or a gas therein.
- the invention finds use for cleaning and/or disinfecting surfaces, food such as fruit, vegetables, crops, cut flowers or mammalian tissues (including wounds).
- the invention provides a stabilised solution or formulation comprising hypohalous acid, wherein the solution or formulation has an available free halide (AFC) content of from about 10 to about 10,000 parts per million, a pH of from about 3.0 to 7.0, and is packaged in a double-compartment packaging of the type used in the aerosol industry, notably in cosmetics or personal care products.
- AFC available free halide
- An aluminium or tinplate can pressure-resisting external container
- a valve on which a flexible container of variable volume (e.g., a multilayer film bag) and containing the product to be dispensed is affixed or welded.
- the propellant liquid or compressed gas
- the propellant is contained inside the pressure-resisting external container, outside the flexible container of variable volume, and squeezes the flexible container of variable volume to release the product through the valve.
- the flexible container of variable volume containing the fluid to be delivered is in the form or shape of a pouch or flexible receptacle and is equipped with an actuator that allows the activation of a valve for the delivery of the fluid, the whole being located inside a pressure-resisting external container (e.g., an aluminium or tinplate can).
- a pressure-resisting external container e.g., an aluminium or tinplate can.
- the internal volume of the pressure-resisting external container comprises, between its wall and the flexible container of variable volume being filled with the fluid to be delivered, a neutral gas under a pressure sufficient to exert on the flexible container of variable volume a pneumatic constraint sufficient to allow the delivery of the therein contained fluid when the aforementioned valve permitting said delivery is operated by the aforementioned actuator.
- the pressure-resisting external container is preferably capable of resisting an elevated internal pressure, which is notably higher than 5 bars, preferably higher than 8 bars, more preferably higher than 12 bars and possibly even capable of supporting pressures in excess of 20 bars.
- the flexible container of variable volume containing the fluid to be delivered and the pressure-resisting external container are both made of transparent materials, allowing the user to see the fluid to be delivered and determine at every moment the state of filling of the device.
- the flexible container of variable volume containing the fluid to be delivered is made in polyethylene terephthalate (PET); this material not only exhibits good mechanical resistance, but also reasonably good gas barrier properties.
- PET exhibits very low gas permeation compared with most polymers such as polystyrene, polyethylene and polypropylene (Fernandez-Menendez et al., Polymer Testing 90 (2020) 106729); for this reason, PET bottles are widely used as containers for carbonated liquids (e.g. carbonated water, soft drinks, beer, etc.).
- the propellant may be at least one of, or a mixture of, the gases selected from the group air, nitrogen, argon, carbon dioxide or another gas.
- the gas is inserted in the volume delimited by the internal wall of the pressure-resisting external container and the external wall of the flexible container of variable volume being filled with the fluid to be delivered, in any appropriate form, particularly gaseous or dissolved in an appropriate liquid or solid medium, the release of the dissolved gas in the liquid or solid medium making it possible to maintain a constant pressure in the internal volume delimited by the internal wall of the pressure-resisting external container and the external wall of the flexible container of variable volume being filled with the fluid to be delivered.
- hypohalous acid may be produced chemically in accordance with some embodiments (e.g., by acidification of hypohalite), the hypohalous acid may also be produced electrochemically.
- the hypohalite solution may be generated by electrolysis of a halide salt, such as sodium chloride, and may comprise a mixture of oxidising species such as predominantly sodium hypochlorite and hypochlorous acid.
- Hypochlorous acid and hypochlorite are in equilibrium and the position of the equilibrium is determined predominantly by the pH (that is, pH affects the concentration of each component).
- An electrolysed sodium chloride solution with a pH of 8.8 to 10.0 has a purity of about > 95% sodium hypochlorite (see Figure 2); by reducing the pH to less alkaline values, the available free chlorine content can be converted into the more effective hypochlorous acid form.
- the pH-adjusted solution may have a pH of from about 4.0 to about 7.5, but in certain embodiments has a pH of from about 4.4 to about 6.75, or a pH of from about 5 to about 6.75, or a pH of from about 5.4 to about 6.4, or a pH of from about 6.0 to about 6.4.
- the solution will contain mostly ( ⁇ 95%) hypochlorous acid with respect to hypochlorite (see Figure 2).
- any suitable acid that does not react with the hypohalite can be used; for example, the following acids may be considered: hydrochloric acid (HCI), sulphuric acid (H2SO4), chloric acid (HCIO3), perchloric acid (HCIO4), nitric acid (HNO3), phosphoric acid (H3PO4), acetic acid (CH3COOH), carbonic acid (H2CO3), boric acid (H3BO3).
- HCI hydrochloric acid
- H2SO4 sulphuric acid
- H2SO4 chloric acid
- HCIO3 chloric acid
- HCIO4 perchloric acid
- HNO3 nitric acid
- H3PO4 phosphoric acid
- acetic acid CH3COOH
- carbonic acid H2CO3
- boric acid H3BO3
- the final solution may comprise or consist essentially of hypochlorous acid as the active agent, in some embodiments it may contain other hypohalous acids (e.g., HOBr, or mixture thereof). In some embodiments, the solution contains other oxidising or radical producing species such as a hypohalite (e.g., hypochlorite), hydroxide, H2O2 and O3, among others.
- hypohalite e.g., hypochlorite
- hydroxide e.g., H2O2 and O3, among others.
- the biocidal activity of the solution can be expressed in terms of available free chlorine or AFC. While the invention is applicable to an AFC range of from about 10 to about 10,000 ppm (or to about 5,000 ppm), in certain embodiments, the solution has a relatively high AFC content and is suitable for use with mammalian tissues or agricultural products. For example, the solution may have an AFC content of from about 100 to 1,000 ppm, or 100 to 500 ppm, or about 150 to about 250 ppm. Other AFC levels may be employed and may be selected based upon the intended application. For example, without any limitation, for surface disinfection the AFC may be in the range of about 140 to about 2,000 ppm, or about 400 to about 1 ,000 ppm.
- Also disclosed herein is a method for preparing a stabilised hypohalous acid solution packaged in a container of variable volume of the type used to deliver fluids under pressure.
- the method involves introducing an empty flexible container of variable volume, having the form or shape of a pouch or flexible receptacle and equipped with a mounting cup also comprising a gasket, into a pressure-resisting external container. After positioning the mounting cup comprising the gasket on the edge of the opening of the pressure-resisting external container, the mounting cup is crimped on the external edge of the opening of the pressure-resisting external container.
- a neutral gas under pressure is introduced in a quantity sufficient for bringing the pressure to a value preferably comprised between about 1.5 bars and about 6 bars, the precise value of the said pressure being chosen in accordance with the nature of the fluid to be delivered and the final application. Further details about the assembly of the just described device can be found in U.S. Patent 2008/0272145, which is hereby incorporated by reference in its entirety.
- a suitable tool for example an under the cup gasser crimper of the type marketed by the company Pamasol Willi Mader AG, DriesbOelstrasse 2, CFI-8808 Pfaffikon, SZ Switzerland under the name "Tete UTC” (i.e. “UTC Head”).
- This tool ensures the tightness at the level of the upper surface of the pressure-resisting external container and lifts slightly the mounting cup, using a connection by vacuum to pull by aspiration the mounting cup into a seat, and to permit the introduction under pressure of a neutral gas or of compressed air.
- the mounting cup is pressed against the external edge of the opening of the pressure-resisting external container, then a crimping is made between the mounting cup and the pressure-resisting external container. During this operation, a pressure is maintained by the head to compress the gasket included within the mounting cup and therefore ensure a good tightness between the mounting cup and the pressure-resisting external container.
- the internal flexible container of variable volume is then filled with the fluid intended to be delivered under pressure.
- This quantity determining unit generally comprises a device for volumetric quantity determination under high pressure and a filling nozzle.
- the solution thus becomes progressively more stable, the stabilising effect being due, at least in part, to the free radical scavenging ability of dissolved inorganic carbon (which generally includes carbonates, bicarbonates, carbonic acid and dissolved CO2) to thereby slow down the decomposition of the hypohalous acid.
- dissolved inorganic carbon which generally includes carbonates, bicarbonates, carbonic acid and dissolved CO2
- the solution inserted in the internal flexible container has originally an alkaline pH
- a larger amount of carbon dioxide will be required to stabilise the hypohalous acid.
- the pH of the solution can also be reduced prior to packaging by adding acid, as previously discussed. In such a case, the diffusion of carbon dioxide through the PET layer of the flexible container will take place anyway, thus providing the stabilising effect.
- hypohalous acid solution may be in the form of a liquid
- the solution may take the form of a cream, gel (e.g. silicate-based gel), and/or foam by the addition of conventional ingredients known in the art.
- topical formulations of electrochemical solutions are disclosed in US 2005/0196462, which is hereby incorporated by reference in its entirety. In these embodiments, the formulation is better contained around the application site by limiting solution run-off.
- convenient applicators for creams, foams, and the like are known, and may be used in accordance with the present invention. Since the solutions of the invention provide the potential for low conductivity, even with relatively high AFC content, and at “skin- friendly” pH levels, the solutions of the invention are particularly suitable for hydrogel formulations.
- the composition has an AFC content of greater than about 150 ppm, greater than about 200 ppm, greater than about 250 ppm, greater than about 300 ppm, or greater than about 400 ppm.
- the formulation may have a conductivity of from about 0.3 mS/cm to about 12 mS/cm, such as from about 0.5 mS/cm to about 10 mS/cm in some embodiments.
- hydrogel formulations in some embodiments have a pH of from about 5 to about 7, or from about 6 to about 6.5 in other embodiments.
- the hydrogels may be prepared from silicate- based carriers, such as sodium magnesium fluorosilicate (e.g., from about 0.5% to about 5%), and may employ an additional buffer for targeting the pH.
- An exemplary buffer is phosphoric acid.
- the hypohalous acid solution of the invention may also be hypertonic, hypotonic, or isotonic with respect to physiological fluids (blood, plasma, tears, etc.).
- the solution may contain varying levels of salinity, such as from 0.01 to about 2.0%.
- the solution contains from about 0.02% to about 0.9% w/v NaCI when intended for use in medicine.
- the solution may be a normal saline solution (about 0.91% w/v NaCI).
- the solution may contain from about 0.01 to 2.0% w/v of one or more salts, such as a halide salt, e.g. NaCI, KCI, or a mixture of salts or halide salts.
- the salt or halide salt may be a salt of an alkali metal or alkaline earth metal, such as sodium, potassium, calcium, or magnesium.
- the electrolysed solution is generated using a mixture of physiologically balanced salts, as disclosed in U.S. Patent 6,426,066, which is hereby incorporated by reference in its entirety.
- Such salts may include potassium halides (e.g., KCI) and magnesium halides (e.g., MgCh).
- Still other aspects of the invention provide methods of disinfecting or cleansing a mammalian tissue, such as a wound or burn, or disinfecting or cleansing a hard surface, or for treating or preserving a food product or cut flowers. Due to the stability of the hypohalous acid solutions, such methods need not be performed proximately to the production of the biocidal solution, and the solution may be prepared well in advance of its use.
- the solutions and formulations of the invention may be used as sterilising, disinfecting and biocidal solutions for human and animal care.
- the solutions are non-hazardous, non-irritating, non-sensitising to the skin, non-irritating to the eyes, not harmful if swallowed, and show no evidence of mutagenic activity.
- the method of the invention provides for moistening, lubricating, irrigating, cleaning, deodorising, disinfecting, or debriding a wound by rinsing, washing or immersing the wound, with or in, the stabilised hypohalous acid solutions, or by applying the solution to the wound and/or wound dressing.
- the wound may or may not be infected, and thus the method of the invention is useful for treating infected wounds and useful for preventing infection of uninfected wounds.
- the invention provides a convenient means for wound care and management and may be used in combination with the apparatus and methods described in U.S. 2010/030132, which is hereby incorporated by reference in its entirety.
- the method may comprise supplying the stabilised solution to a wound site by one or more of soak, scrub, pulsed lavage, hydrosurgery, and ultrasound to effectively debride and disinfect a wound or tissue.
- the solution may be delivered before, during and/or after negative pressure wound therapy to promote proper wound healing physiology.
- the method may employ a wound dressing for coordinating debridement by infusion of hypochlorous acid with negative pressure therapy.
- the invention may be used in combination with a wound treatment apparatus and/or wound dressing.
- the invention allows for an initial stabilised hypochlorous acid solution soak and/or scrub to both debride and disinfect the wound or tissue, followed by the application of negative pressure to the wound or tissue using the stabilised hypochlorous acid solution as an irrigating agent to control wound bioburden, remove excess exudate, and promote formation of granulation tissue.
- the method also involves seamless transition to the stabilised hypohalous acid solution infusion (e.g., active or passive infusion without negative pressure).
- seamless transition can be effected via a wound dressing which allows for controlled infusion of stabilised hypochlorous acid solution with controlled vacuum source.
- continued cell proliferation and regeneration continues without disruption of the wound bed, once the endpoints of negative pressure therapy have been obtained.
- the wound needing care is a stage l-IV pressure ulcer, stasis ulcer, diabetic ulcer, post-surgical wound, burn, cut, abrasion, or a minor irritation of the skin.
- the wound is rinsed, washed, or immersed in the solution periodically over at least two weeks, but treatment may continue periodically for over about 4 weeks, about 9 weeks, or more.
- the wound in some embodiments, is rinsed with the solution at least once a week, but may be treated with the solution at least twice a week, or more frequently.
- the invention provides a method for treating an infected or colonised wound, tissue, surgical cavity, or bone, and a method for reducing wound bioburden.
- the treatment solution in accordance with the invention is generally effective for killing or inactivating a broad spectrum of bacterial, fungal, and viral pathogens, including S. aureus, P. aeruginosa, E. coli, Enterococcus spp., C. difficile, and Candida spp..
- the solution does not produce resistant species, making the methods desirable over the delivery of traditional antibiotics.
- the solution of the invention is particularly suitable for use in conjunction with stem cell and growth factor therapy, including the use of genetically engineered cells and engineered tissue and allografts and organs for transplant in various treatments.
- the solution or formulation thereof is applied for the control of inflammation, including an inflammatory reaction or hyper-inflammation of the skin.
- the solution or formulation thereof may be applied for use in a method as described in U.S. 2007/0196357 or U.S. 2010/0285151, which are hereby incorporated by reference.
- the solution or composition of the invention is applied (e.g., to an affected area) for treatment of a patient having a dermatosis, atopic dermatitis, skin allergy, rosacea, psoriasis, or acne, among others.
- the solution may be formulated as a hydrogel, for example, as described elsewhere herein.
- this invention is advantageously used against microbes on surfaces because of its fast activity against bacterial spores, fungi, and other resistant microorganisms. Because of its effectiveness and the speed at which it acts, the invention meets a substantial public health need, and one that is not adequately addressed by current commonly used antimicrobial agents. Accordingly, application of the solution to various surfaces and materials is useful to control microbial contamination, not only for the care and management of wounds, but for disinfecting hard surfaces such as medical or dental equipment, preserving and decontaminating food products, water treatment, as well as other industrial and agricultural applications.
- the solution or composition of the invention is applied to crops (pre- or post-harvest) or cut flowers for their preservation and/or for improving the overall quality of the product.
- the solution is potassium based and has one or more utilities (e.g., methods of use) as disclosed in PCT/US2011/43590, which is hereby incorporated by reference in its entirety.
- Bacterial spores have a unique chemical composition of spore layers that make them more resistant than vegetative bacteria to the antimicrobial effects of chemical and physical agents.
- the unique chemical composition of fungal cells, especially mould spores makes them more resistant to chemical and physical agents than other microorganisms. This resistance can be particularly troublesome when the spores or fungi are located on surfaces such as food, food contact sites, ware, hospitals and veterinary facilities, surgical implements, and hospital and surgical linens and garments.
- Control of the mould Chaetomium funicola, and of bacterial spore-forming microorganisms of the Bacillus species can be especially important during food packaging, particularly during cold or hot aseptic filling of food and beverage products.
- Microorganisms of the Bacillus species include Bacillus cereus, Bacillus mycoides, Bacillus subtilis, Bacillus anthracis, and Bacillus thuringiensis. These latter microorganisms share many phenotypical properties, have a high level of chromosomal sequence similarity, and are known enterotoxin producers.
- Bacillus cereus is one of the most problematic because it has been identified as possessing increased resistance to germicidal chemicals used to decontaminate environmental surfaces.
- the term “surface” refers to both hard and soft surfaces and includes, but are not limited to, tile grout, plaster, drywall, ceramic, cement, clay, bricks, stucco, plastic, wallpaper, fabric, tiles, cement and vinyl flooring, heating and/or cooling fins, filters, vanes, baffles, vents, crevices in walls or ceilings, paper and wood products such as lumber, paper, and cardboard, woven products such as blankets, clothing, carpets, drapery and the like.
- the term surface also includes human surfaces, animal surfaces, military equipment, transportation equipment, children’s items, plant surfaces, seeds, outdoor surfaces, soft surfaces, air, wounds, and medical instruments, and the like.
- Example 1 Solutions of free chlorine packaged using nitrogen aas as the propellant
- Figures 3A and 3B show averages of three AFC and pH measurements for aqueous solutions of free chlorine (AFC * 380 ppm, initial pH » 9.8) produced by electrochemical treatment of a diluted saline, pH-adjusted to about 7 with hydrochloric acid.
- AFC * 380 ppm, initial pH » 9.8 produced by electrochemical treatment of a diluted saline, pH-adjusted to about 7 with hydrochloric acid.
- Different double-compartment packaging of the type used to deliver fluids under pressure were filled with aliquots of the same solution, stored at 40°C to accelerate the deterioration of the solution, and kept unopened until measurement.
- the solution should be stored at 25°C or at 20°C or less for greater stability; however, for stability testing, accelerated tests can be performed by storing the solution at a higher temperature, and the shelf- life predicted from accelerated data by extrapolation.
- Example 2 Stabilised solutions of free chlorine packaged using gaseous carbon dioxide as the propellant
- an aqueous solution of free chlorine (AFC * 380 ppm, initial pH » 9.8) was produced by electrochemical treatment of a diluted saline and then pH-adjusted to about 7 with hydrochloric acid.
- AFC * 380 ppm, initial pH » 9.8 was produced by electrochemical treatment of a diluted saline and then pH-adjusted to about 7 with hydrochloric acid.
- Different double-compartment packaging of the type used to deliver fluids under pressure were filled with aliquots of the same solution, stored at 40°C to accelerate the deterioration of the solution, and kept unopened until measurement. Aluminium cans and flexible PET pouches equipped with an aluminium mounting cap and a valve were used; however, this time gaseous carbon dioxide was used as the propellant.
- Figures 4A and 4B show averages of three AFC and pH measurements as a function of time; also shown is the non-linear regression (solid line) with 95% prediction intervals (broken lines).
- the results clearly show how solutions packaged in double compartment packaging of the type used to deliver fluids under pressure are more stable over time when pressurised with carbon dioxide, not only as regards their AFC content (more than 80 days were required to see a 50% reduction) but above all as regards the change in pH. This surprising result is attributable to the propellant, which appears to be able to slowly permeate through the minimally permeable PET layer of the flexible PET pouch, and to dissolve in the solution therein contained.
- the solution thus becomes progressively more stable, the stabilising effect being due, at least in part, to the free radical scavenging ability of dissolved inorganic carbon (which generally includes carbonates, bicarbonates, carbonic acid and dissolved CO2) to thereby slow down the decomposition of the hypohalous acid.
- dissolved inorganic carbon which generally includes carbonates, bicarbonates, carbonic acid and dissolved CO2
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Pest Control & Pesticides (AREA)
- Polymers & Plastics (AREA)
- Plant Pathology (AREA)
- Food Science & Technology (AREA)
- Environmental Sciences (AREA)
- Nutrition Science (AREA)
- Agronomy & Crop Science (AREA)
- Dentistry (AREA)
- Dermatology (AREA)
- Dispersion Chemistry (AREA)
- Mechanical Engineering (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Containers And Packaging Bodies Having A Special Means To Remove Contents (AREA)
Abstract
A stabilised solution or formulation (a liquid or a thixotropic gel) of an antimicrobial solution packaged in a double-compartment packaging comprising a flexible container of variable volume therein enclosing the stabilised solution or formulation, said flexible container of variable volume being inserted in a pressure-resisting external container, and comprising a pressurised propellant that is capable of exerting pressure on said flexible container of variable volume and forcing said stabilised solution or formulation out of said flexible container of variable volume upon pressing an actuator that is operatively connected to an ejection valve, wherein the flexible container of variable volume enclosing the stabilised solution or formulation is made of polyethylene terephthalate (PET), and wherein the pressurised propellant is carbon dioxide.
Description
FLUID DELIVERY DEVICE
TECHNICAL FIELD
The present invention relates to a stabilised solution or formulation of hypohalous acid, such as hypochlorous acid (HOCI), packaged in a double-compartment packaging of the type used to deliver fluids under pressure. More specifically, the invention relates to a stabilised solution or formulation of hypohalous acid packaged in a non-aspirating dispenser that comprises a pressure-resisting external container having a flexible container of variable volume therein enclosing the stabilised solutions or formulations (a liquid or a thixotropic gel), and comprising a pressurised gas that is capable of exerting pressure on said flexible container of variable volume and forcing said stabilised solutions or formulations out of said flexible container of variable volume in a steady stream upon pressing an actuator that is operatively connected to an ejection valve. The flexible container of variable volume is free of propellants and does not produce an aerosol. By pressing the actuator, the user can dispense the liquid or gel to a desired surface, in the form of droplets that are free of air or a gas therein. The invention finds use for cleaning and/or disinfecting surfaces, food such as fruit, vegetables, crops, cut flowers or mammalian tissues (including wounds).
BACKGROUND
In many industrial sectors and notably in those of medicines and cosmetic products, it is necessary to deliver under pressure, fluids and principally liquids containing medicinal substances or cosmetics, or products consisting of natural products possibly modified or adapted, thus permitting utilisation of these fluids. For example, isotonic sea water, which finds applications for the washing of the nasal cavities, is one of these fluids.
Typical spray bottles or containers dispense liquids or foams via a mechanical trigger that requires continual pumping thereof to dispense a sprayed product. Since very small amounts of product are dispensed with each pump, numerous pumps are required to adequately cover a surface. The same often exhausts the user and
becomes an ergonomic issue as spraying numerous surfaces, articles, etc., may require a person to take a break or rest.
Moreover, various dispensers, such as a spray bottle, eject a fluid via aspiration such that an aerosol mist is formed. These dispensers are undesirable in sterile situations as the air drawn in by the aspirator may come from a contaminated environment. Moreover, the aerosol droplets are small and therefore subject to being transported to an adjacent sterile environment and contaminating the same.
Various other dispensers contain a sprayable liquid in association with propellants such as volatile hydrocarbons, e.g. butane, propane, or fluorocarbon gases that can pose flammable or toxic problems. In some other cases, the liquid or gel to be dispensed cannot be put in contact with the propellant, as the two fluids are not chemically compatible.
U.S. Patents No. 4,387,833, 4,423,829, 5,927,551 and 4,964,540 describe devices that can be operated in all positions and also in the inverted position. With them the fluid is delivered, not by the action of a propellant gas, but under the action of a mechanical constraint, which is exerted on a container that has the shape of a pouch or flexible receptacle of variable volume; this container generally has a cylindrical shape, is equipped with longitudinal pleats, and is filled with the fluid to be delivered.
Still in the case of the devices disclosed in the aforementioned U.S. Patents, the mechanical constraint, under the action of which the liquid contained within the container of variable volume is delivered under pressure, is exerted by a cylindrical sleeve of elastic material, especially rubber with particular elastic properties, which envelops the container in the form of a pouch or flexible receptacle and whose diameter is slightly larger than the diameter of the container of variable volume when the latter is empty.
The sleeve in question is then put into place and the fluid to be delivered is introduced under pressure into the container which expands against the opposite action of the elastic sleeve of which the compression force exerted on the container increases with the expansion of said container due to the filling with the fluid to be delivered.
The container in the form of a pouch or flexible receptacle is equipped with an actuator that allows the activation of a valve for the delivery of the fluid, the whole being arranged inside a classic container or reservoir of the type used in the aerosol industry, notably in cosmetics or personal care products.
These devices, which are very robust, have always given complete satisfaction to users but are penalised by their manufacturing cost due to the price of the rubber sleeve that is part of their constitution.
Other devices of the type in question exist, wherein a flexible container of variable volume, intended to be filled with the fluid to be delivered, and also equipped with an actuator adapted to activate a valve to permit the fluid under pressure to be delivered, is located inside an external container capable of resisting elevated pressures, notably in excess of 20 bars; this pressure-resisting external container is filled with a neutral gas under pressure, the empty flexible container of variable volume being in place and then the latter is filled with the fluid to be delivered, this fluid being introduced under a pressure which is sufficient to overcome the pressure exerted on the container by the neutral gas with which the pressure-resisting external container is filled, which consequently further increases the pressure of the neutral gas.
In the case of these devices, the constraint exerted on the internal flexible container of variable volume, and under the action of which the pressurised fluid can be delivered, is therefore of a pneumatic nature.
These devices have not known a success comparable to those disclosed above, notably due to their fragility in case of impact or fall, in particular at the level of the connection between the container of variable volume and the actuator, whose operation allows the product under pressure to be delivered.
U.S. Patent Application 2008/0272145 discloses a device that comprises a container of variable volume in the form or shape of a pouch or flexible receptacle of generally cylindrical shape with longitudinal pleats containing the fluid under pressure to be delivered and equipped with an actuator permitting to open a valve to enable the aforementioned fluid to be delivered, the whole being located inside an external
container capable of resisting an elevated internal pressure which is notably superior to 20 bars, the internal volume of the latter container comprises, between its wall and the container of variable volume being filled with the fluid to be delivered, a neutral gas under a pressure sufficient to exert on the container of variable volume a pneumatic constraint sufficient to allow the delivery of the therein contained fluid when the aforementioned valve permitting said delivery is operated by the aforementioned actuator. According to a particular embodiment, the container of variable volume containing the fluid to be delivered and the external pressure-resisting container are both made of transparent materials (e.g. polyethylene terephthalate or PET), allowing the user to see the fluid and to determine at every moment the state of filling of the device as well as any alteration of the fluid which could lead to a change in the aspect of the same (colouring, separation of phases, etc.).
The Patent Application further teaches that the container of variable volume containing the fluid to be delivered and the external pressure-resisting container may be realised using laminated materials wherein at least one of the constitutive layers confers to the laminate sufficient mechanical resistance, while another layer may confer the properties of a barrier to gas, in particular to oxygen, nitrogen and/or carbon dioxide, and/or while another layer may still confer the properties of chemical resistance to the product to be delivered. A layer adapted to confer good mechanical resistance may, for example, be constituted of polyethylene terephthalate or PET. A layer adapted to confer good gas barrier properties may, for example, be realized in Nylon, especially Nylon MXD6, or in ethylene vinyl alcohol resin (or EVOH). A layer adapted to confer good properties of chemical resistance may also, for example, be constituted in polyethylene terephthalate.
Accordingly, the container of variable volume containing the fluid to be delivered may be constituted either by using a laminate of the type PET/Nylon/PET, that is to say comprising an external layer of polyethylene terephthalate, an intermediate layer of Nylon and an internal layer, that is to say a layer intended to be in contact with the fluid to be delivered, also of polyethylene terephthalate; or by using a laminate of the type PET/EVOH/PET.
The pressure-resisting external container may be advantageously realised in the same material. However, bearing in mind that the material constituting this container is not in contact with the fluid to be delivered, it is possible to use a bi-layer laminate, for example in polyethylene terephthalate and Nylon. A material of this type, which does not comprise an internal layer conferring chemical resistance, may also be employed for the constitution of the container of variable volume containing the fluid to be delivered, provided that the fluid to be delivered is chemically compatible with the other layers.
In a subsequent document from the same inventors (U.S. Patent No. 8,752,731), a method for producing a device for dispensing fluid product under pressure, an apparatus for implementing the production method, and a device for dispensing a pressurised fluid product are disclosed. In particular, the latter comprises: a valve equipped with a stem, being suitable for dispensing the pressurised fluid product to outside when the stem is in the actuation position; an internal reservoir with a variable volume, a deformable side wall and a dispensing opening; an external container, made of thermoplastic rigid polymer; an attachment sleeve made of thermoplastic polymer, sealingly attached to the internal reservoir, and also welded to the external container.
The internal reservoir and the valve are placed in the external container so that the axis A of the internal reservoir and the axis B of the external container are coaxial. The external container and the internal reservoir then delimit between them an internal volume in which a pressurised gas is placed. The gas may be at least one of, or a mixture of, the gases selected from the group air, nitrogen, argon, carbon dioxide or another gas. Provision is made for the external container to form a barrier to the gas and to offer a chemical resistance to the gas and a mechanical resistance to a pressure higher than 20 bar. In particular, the external container is made of thermoplastic polymer, such as polyethylene terephthalate (PET) or polyethylene naphthalate (PEN), advantageously transparent, used alone or in the form of a mixture, in order to be able to soften under the action of heat and harden when cooling, in order to form a barrier to the gas and to offer the chemical resistance and mechanical resistance to pressure.
Based on the information provided above, it seems clear that general knowledge supports the use of polyethylene terephthalate (PET) as a layer with not only good
mechanical resistance, but also reasonably good gas barrier properties. PET is known to exhibit very low gas permeation compared with most polymers such as polystyrene, polyethylene and polypropylene (Fernandez-Menendez et al., Polymer Testing 90 (2020) 106729); in addition, PET bottles are widely used as containers for carbonated liquids (e.g. carbonated water, soft drinks, beer, etc.).
WO 2012/129161 is also in support to the above, as it discloses a stabilised solution or formulation packaged in a container for storage or sale, comprising hypochlorous acid and a stabilising amount of dissolved inorganic carbon (DIC) incorporated in the form of a bicarbonate or carbonate of an alkali or alkaline earth metal, wherein the solution or formulation has an available free chlorine (AFC) content of from about 10 to about 10,000 parts per million, a pH of from about 4.0 to 7.0, a DIC-to-AFC molar ratio of from 5:1 to 1 :5, and wherein the container is minimally permeable to CO2 or O2. In particular, Figure 6 in WO 2012/129161 shows the results of an extended stability study of HOCI produced by electrochemical treatment of a NaHCOs-enriched NaCI solution at pH 5.4, bottled in a polyethylene terephthalate (PET) container and stored at room temperature.
The method disclosed in WO 2012/129161 for obtaining the stabilised solution or formulation involves incorporating the DIC (e.g., in the form of carbonate or bicarbonate) by adding it to an electrolyte for electrochemical treatment, or incorporating the DIC (e.g., in the form of carbonate or bicarbonate) by directly adding it to an electrolysed solution comprising hypohalous acid (e.g., HOCI). More in detail, WO 2012/129161 teaches that the stabilised hypochlorous acid solutions (e.g., solutions of greater than 90%, 95%, or 97% HOCI) may be obtained by electrolysis of a saline solution as described in U.S. Patent 7,276,255 or can be prepared by any suitable method or apparatus by incorporating the bicarbonate or carbonate into the dry electrolyte or the solution for electrolysis. The carbonate or bicarbonate can be added to the dry electrolyte in accordance with the desired AFC content of the resulting solution. Hypochlorous acid solutions may be prepared by passing saline solution containing the carbonate/bicarbonate over coated titanium electrodes separated by a semi-permeable ceramic membrane at a current of about 6 to 9 Amps. Electrochemical treatment of saline is described, for example, in U.S. Patent 7,303,660, U.S. Patent 7,828,942, and U.S. Patent 7,897,023. In some embodiments, the bicarbonates or
carbonates are added prior to the formation of hypohalous acid (e.g., prior to the electrochemical treatment), and in other embodiments, the bicarbonates or carbonates are added to the solution after formation of hypohalous acid. For example, the bicarbonate(s) or carbonate(s) may be added to the precursor solution, the electrolyte, and/or the end solution.
When dissolved in water, a bicarbonate or carbonate of an alkali or alkaline earth metal imparts an alkaline pH to the solution. It will therefore be apparent to those skilled in the art that, in order to obtain a stabilised solution or formulation comprising hypochlorous acid and a stabilising amount of dissolved inorganic carbon (DIC) incorporated in the form of a bicarbonate or carbonate of an alkali or alkaline earth metal, and having a pH of from about 4.0 to 7.0, a particular electrolysis apparatus is required, comprising one or more electrolytic cells, each of which comprises an anode, a cathode and a separator (diaphragm or membrane) capable of avoiding mixing between the solution treated at the anode and the one treated at the cathode. When subjected to electrolytic treatment on the anode side of the just described electrolytic cell, the saline solution (i.e., a solution containing an alkali or alkaline earth halogenide) entering the cell is converted into a solution containing the corresponding hypohalous acid. If the saline solution originally has an alkaline pH (due to the presence of a bicarbonate or carbonate of an alkaline or alkaline earth metal), depending on the residence time of the solution in the electrolytic cell and the electric current used, the electrolytic treatment on the anode side of the electrolytic cell above described may allow to lower the solution pH up to acidic values (i.e. lower than 7), and thus to obtain a solution or formulation with the characteristics described by Panicheva et al. (WO 2012/129161). Unfortunately, this can only be obtained by using an electrolysis apparatus in which the anode and cathode compartments are kept separated by using a diaphragm or a membrane.
Based on the above, there is still an unmet need for a simple way to prepare a hypohalous acid solution that has a high AFC content, has sufficient stability and/or other properties required to be commercially useful in medical and other commercial settings, and is not irritating or harmful to humans. The claimed invention meets these and other objectives.
Throughout this specification, unless the context requires otherwise, the word “comprise”, or variations such as “comprises” or “comprising”, will be understood to imply the inclusion of a stated element, integer or step, or group of elements, integers or steps, but not the exclusion of any other element, integer or step, or group of elements, integers or steps.
Any discussion of documents, acts, materials, devices, articles or the like which has been included in the present specification is solely for the purpose of providing a context for the present invention. It is not to be taken as an admission that any or all of these matters form part of the prior art base or were common general knowledge in the field relevant to the present invention, as it existed before the priority date of each claim of this specification.
SUMMARY OF THE INVENTION
The present invention relates to a stabilised hypohalous acid solution or formulation thereof, conveniently packaged for sale in a double-compartment packaging of the type used to deliver fluids under pressure. The invention further relates to methods of use for disinfecting mammalian tissue, including wounds and burns, disinfecting or cleansing hard surfaces, treating (e.g., preserving and/or disinfecting) food products or cut flowers, among other uses.
More specifically, the invention relates to a stabilised solution or formulation of hypohalous acid packaged in a non-aspirating dispenser that comprises a pressure- resisting external container having a flexible container of variable volume therein enclosing the stabilised solution or formulation (a liquid or a thixotropic gel), and comprising a pressurised gas that is capable of exerting pressure on said flexible container of variable volume and forcing said stabilised solution or formulation out of said flexible container of variable volume in a steady stream upon pressing an actuator that is operatively connected to an ejection valve. The flexible container of variable volume is free of propellants and does not produce an aerosol. By pressing the actuator, the user can dispense the liquid or gel to a desired surface, in the form of droplets that are free of air or a gas therein. The invention finds use for cleaning and/or
disinfecting surfaces, food such as fruit, vegetables, crops, cut flowers or mammalian tissues (including wounds).
In a first aspect, the invention provides a stabilised solution or formulation comprising an antimicrobial solution, for example hypochlorous acid, wherein the solution or formulation has an available free chlorine (AFC) content of from about 10 to about 10,000 parts per million, a pH of from about 3.0 to 7.0, and is packaged in a double compartment packaging of the type used to deliver fluids under pressure. The flexible container of variable volume containing the fluid to be delivered is in the form or shape of a pouch or flexible receptacle and is equipped with an actuator that allows the activation of a valve for the delivery of the fluid, the whole being located inside a pressure-resisting external container or reservoir of the type used in the aerosol industry, notably in cosmetics or personal care products. The internal volume of the pressure-resisting external container comprises, between its wall and the flexible container of variable volume being filled with the fluid to be delivered, a neutral gas under a pressure sufficient to exert on the flexible container of variable volume a pneumatic constraint sufficient to allow the delivery of the therein contained fluid when the aforementioned valve permitting said delivery is operated by the aforementioned actuator.
In a further aspect, the present invention provides a method for disinfecting or treating a mammalian tissue, the method comprising applying the solution or formulation to a mammalian tissue in need of disinfection or treatment.
In another aspect, the present invention provides a method for disinfecting or cleansing a hard surface comprising applying the solution or formulation according to the first aspect of the invention to the hard surface, and optionally, wherein the hard surface comprises porcelain, glass, steel, iron, ceramic or polymeric material.
In a further aspect, the present invention provides a method of treating a food product comprising applying the solution or formulation according to the first aspect of the invention to the food product.
Also disclosed herein is a stabilised hypohalous acid solution. The solution may have an available free chlorine (AFC) content of from about 10 to about 10,000 parts per
million, and a pH of from about 3.0 to about 7.0. For example, in certain embodiments, the solution has a pH of from about 6.1 to about 6.75. In certain embodiments, the solution contains hypochlorous acid, and is prepared by electrolysis of saline. The solution is stabilised, as determined by its limited change in pH and/or AFC over time, for at least one month, but in various embodiments, the solution is stabilised for at least six months, at least one year, or more.
In certain embodiments, the solution comprises HOCI produced by electrolysis of saline, and the solution may have an AFC content of from about 100 to about 500 parts per million, a pH in the range of about 3.0 to about 7.0, and a salinity of from about 0.02% to about 1.0%. In certain embodiments, the HOCI solution is formulated as a hydrogel.
Also disclosed herein is a method for preparing a stabilised hypohalous acid solution packaged in a double-compartment packaging of the type used to deliver fluids under pressure. The method involves assembling a device of the type used in the aerosol industry, notably in cosmetics or personal care products; in particular, the device is a double-compartment packaging. For example, as schematised in Figure 1, an aluminium or tinplate can (pressure-resisting external container) is closed by a valve on which a flexible container of variable volume (e.g., a multilayer film bag) and containing the product to be dispensed is affixed or welded. The propellant (liquid or compressed gas) is contained inside the pressure-resisting external container and outside the flexible container of variable volume, and squeezes the flexible container of variable volume to release the product through the valve. This solution makes it possible to dispense the product in whatever position the double-compartment packaging is held.
Other aspects and embodiments of the invention will be apparent from the following detailed description of the invention.
DESCRIPTION OF THE FIGURES
Figure 1 schematises the assembly procedure for a device of the type used in the aerosol industry, notably in cosmetics or personal care products; in particular, the device is a double-compartment packaging. As shown, the assembly procedure
involves several steps: 1A placing a bag with affixed valve inside a container, 1B gassing (air/nitrogen) followed by crimping of the valve into the container, 1C filling the product into the bag, 1 D positioning of actuator and cap.
Figure 2 shows the relative percentage of the HOCI and NaOCI species present in a free chlorine aqueous solution at a temperature of 20 °C and 0.1 M ionic strength, as a function of pH (Dissociation of hypochlorous acid, in White’s Handbook of Chlorination and Alternative Disinfectants (5th edition), Black & Veatch Corporation, 2010).
Figures 3A and 3B show the change in AFC and pH over storage time of packaged aqueous solutions of free chlorine (produced by electrochemical treatment of a NaCI solution), whose pH was initially adjusted to about 7 with hydrochloric acid; different double-compartment packaging of the type used to deliver fluids under pressure were filled with aliquots of the same solution, stored at 40°C to accelerate the deterioration of the solution, and kept unopened until measurement. Aluminium cans and flexible PET pouches equipped with a valve and an aluminium mounting cap were used; nitrogen gas was used as the propellant. The data shown are averages of three values; also shown is the linear regression (solid line) with 95% prediction intervals (broken lines).
Figures 4A and 4B show the change in AFC and pH over storage time of packaged aqueous solutions of free chlorine (produced by electrochemical treatment of a NaCI solution), whose pH was initially adjusted to about 7 with hydrochloric acid; different double-compartment packaging of the type used to deliver fluids under pressure were filled with aliquots of the same solution, stored at 40°C to accelerate the deterioration of the solution, and kept unopened until measurement. Aluminium cans and flexible PET pouches equipped with a valve and an aluminium mounting cap were used; however, this time gaseous carbon dioxide was used as the propellant. The data shown are averages of three values, along with the non-linear regression (solid line) with 95% prediction intervals (broken lines).
DETAILED DESCRIPTION
The present invention relates to a stabilised solution or formulation of hypohalous acid packaged in a non-aspirating dispenser that comprises a pressure-resisting external container having a flexible container of variable volume therein enclosing the stabilised solution or formulation (a liquid or a thixotropic gel), and comprising a pressurised gas that is capable of exerting pressure on said flexible container of variable volume and forcing said stabilised solution or formulation out of said flexible container of variable volume in a steady stream upon pressing an actuator that is operatively connected to an ejection valve. The flexible container of variable volume is free of propellants and does not produce an aerosol. By pressing the actuator, the user can dispense the liquid or gel to a desired surface, in the form of droplets that are free of air or a gas therein. The invention finds use for cleaning and/or disinfecting surfaces, food such as fruit, vegetables, crops, cut flowers or mammalian tissues (including wounds).
In a first aspect, the invention provides a stabilised solution or formulation comprising hypohalous acid, wherein the solution or formulation has an available free halide (AFC) content of from about 10 to about 10,000 parts per million, a pH of from about 3.0 to 7.0, and is packaged in a double-compartment packaging of the type used in the aerosol industry, notably in cosmetics or personal care products. An aluminium or tinplate can (pressure-resisting external container) is closed by a valve on which a flexible container of variable volume (e.g., a multilayer film bag) and containing the product to be dispensed is affixed or welded. The propellant (liquid or compressed gas) is contained inside the pressure-resisting external container, outside the flexible container of variable volume, and squeezes the flexible container of variable volume to release the product through the valve. This solution makes it possible to dispense the product in whatever position the double-compartment packaging is held.
The flexible container of variable volume containing the fluid to be delivered is in the form or shape of a pouch or flexible receptacle and is equipped with an actuator that allows the activation of a valve for the delivery of the fluid, the whole being located inside a pressure-resisting external container (e.g., an aluminium or tinplate can). The internal volume of the pressure-resisting external container comprises, between its wall and the flexible container of variable volume being filled with the fluid to be delivered, a neutral gas under a pressure sufficient to exert on the flexible container of variable
volume a pneumatic constraint sufficient to allow the delivery of the therein contained fluid when the aforementioned valve permitting said delivery is operated by the aforementioned actuator.
The pressure-resisting external container is preferably capable of resisting an elevated internal pressure, which is notably higher than 5 bars, preferably higher than 8 bars, more preferably higher than 12 bars and possibly even capable of supporting pressures in excess of 20 bars.
According to a particular embodiment, the flexible container of variable volume containing the fluid to be delivered and the pressure-resisting external container are both made of transparent materials, allowing the user to see the fluid to be delivered and determine at every moment the state of filling of the device.
In a preferred embodiment, the flexible container of variable volume containing the fluid to be delivered is made in polyethylene terephthalate (PET); this material not only exhibits good mechanical resistance, but also reasonably good gas barrier properties. In particular, PET exhibits very low gas permeation compared with most polymers such as polystyrene, polyethylene and polypropylene (Fernandez-Menendez et al., Polymer Testing 90 (2020) 106729); for this reason, PET bottles are widely used as containers for carbonated liquids (e.g. carbonated water, soft drinks, beer, etc.).
The propellant (liquid or compressed gas) may be at least one of, or a mixture of, the gases selected from the group air, nitrogen, argon, carbon dioxide or another gas. The gas is inserted in the volume delimited by the internal wall of the pressure-resisting external container and the external wall of the flexible container of variable volume being filled with the fluid to be delivered, in any appropriate form, particularly gaseous or dissolved in an appropriate liquid or solid medium, the release of the dissolved gas in the liquid or solid medium making it possible to maintain a constant pressure in the internal volume delimited by the internal wall of the pressure-resisting external container and the external wall of the flexible container of variable volume being filled with the fluid to be delivered.
While the solution or formulation comprising hypohalous acid may be produced chemically in accordance with some embodiments (e.g., by acidification of hypohalite),
the hypohalous acid may also be produced electrochemically. The hypohalite solution may be generated by electrolysis of a halide salt, such as sodium chloride, and may comprise a mixture of oxidising species such as predominantly sodium hypochlorite and hypochlorous acid. Hypochlorous acid and hypochlorite are in equilibrium and the position of the equilibrium is determined predominantly by the pH (that is, pH affects the concentration of each component). An electrolysed sodium chloride solution with a pH of 8.8 to 10.0 has a purity of about > 95% sodium hypochlorite (see Figure 2); by reducing the pH to less alkaline values, the available free chlorine content can be converted into the more effective hypochlorous acid form. Thus, the pH-adjusted solution may have a pH of from about 4.0 to about 7.5, but in certain embodiments has a pH of from about 4.4 to about 6.75, or a pH of from about 5 to about 6.75, or a pH of from about 5.4 to about 6.4, or a pH of from about 6.0 to about 6.4. At a pH lower than 6.2 the solution will contain mostly (< 95%) hypochlorous acid with respect to hypochlorite (see Figure 2).
To reduce the pH of a hypohalite solution having originally an alkaline pH (e.g. a pH comprised between 8.8 to 10.0) and convert the hypohalite into the more effective hypohalous acid form, any suitable acid that does not react with the hypohalite can be used; for example, the following acids may be considered: hydrochloric acid (HCI), sulphuric acid (H2SO4), chloric acid (HCIO3), perchloric acid (HCIO4), nitric acid (HNO3), phosphoric acid (H3PO4), acetic acid (CH3COOH), carbonic acid (H2CO3), boric acid (H3BO3).
While the final solution may comprise or consist essentially of hypochlorous acid as the active agent, in some embodiments it may contain other hypohalous acids (e.g., HOBr, or mixture thereof). In some embodiments, the solution contains other oxidising or radical producing species such as a hypohalite (e.g., hypochlorite), hydroxide, H2O2 and O3, among others.
The biocidal activity of the solution can be expressed in terms of available free chlorine or AFC. While the invention is applicable to an AFC range of from about 10 to about 10,000 ppm (or to about 5,000 ppm), in certain embodiments, the solution has a relatively high AFC content and is suitable for use with mammalian tissues or agricultural products. For example, the solution may have an AFC content of from about 100 to 1,000 ppm, or 100 to 500 ppm, or about 150 to about 250 ppm. Other
AFC levels may be employed and may be selected based upon the intended application. For example, without any limitation, for surface disinfection the AFC may be in the range of about 140 to about 2,000 ppm, or about 400 to about 1 ,000 ppm.
Also disclosed herein is a method for preparing a stabilised hypohalous acid solution packaged in a container of variable volume of the type used to deliver fluids under pressure. The method involves introducing an empty flexible container of variable volume, having the form or shape of a pouch or flexible receptacle and equipped with a mounting cup also comprising a gasket, into a pressure-resisting external container. After positioning the mounting cup comprising the gasket on the edge of the opening of the pressure-resisting external container, the mounting cup is crimped on the external edge of the opening of the pressure-resisting external container. In the volume comprised between the wall of the pressure-resisting external container and the external surface of the internal flexible container of variable volume, a neutral gas under pressure is introduced in a quantity sufficient for bringing the pressure to a value preferably comprised between about 1.5 bars and about 6 bars, the precise value of the said pressure being chosen in accordance with the nature of the fluid to be delivered and the final application. Further details about the assembly of the just described device can be found in U.S. Patent 2008/0272145, which is hereby incorporated by reference in its entirety. In view of introducing the neutral gas, one may proceed using a suitable tool, for example an under the cup gasser crimper of the type marketed by the company Pamasol Willi Mader AG, DriesbOelstrasse 2, CFI-8808 Pfaffikon, SZ Switzerland under the name "Tete UTC" (i.e. “UTC Head”). This tool ensures the tightness at the level of the upper surface of the pressure-resisting external container and lifts slightly the mounting cup, using a connection by vacuum to pull by aspiration the mounting cup into a seat, and to permit the introduction under pressure of a neutral gas or of compressed air. Once the gas has been introduced, the mounting cup is pressed against the external edge of the opening of the pressure-resisting external container, then a crimping is made between the mounting cup and the pressure-resisting external container. During this operation, a pressure is maintained by the head to compress the gasket included within the mounting cup and therefore ensure a good tightness between the mounting cup and the pressure-resisting external container. The internal flexible container of variable volume is then filled with the fluid intended to be delivered under pressure. In this respect, it is possible to have recourse
to a so-called metering unit, for instance that which is marketed by the company Pamasol Willi Mader AG, Driesbiielstrasse 2, CH-8808 Pfaffikon, SZ Switzerland under the name "Remplisseur volumetrique sous pression" (i.e. “Volumetric pressure filling machine”). This quantity determining unit generally comprises a device for volumetric quantity determination under high pressure and a filling nozzle. Once the mounting cap is crimped on the pressure-resisting external container, the whole is positioned under the filling nozzle, which is part of the metering unit, and the nozzle is operated to come down and to ensure tightness on the mounting cup. The fluid is introduced under pressure through the valve in order to fill the internal flexible container.
The authors of the present invention have surprisingly discovered that it is possible to obtain a stabilised hypohalous acid solution packaged in a double-compartment packaging of the type used in the aerosol industry, notably in cosmetics or personal care products, simply by selecting an internal flexible container (of variable volume, to contain the fluid to be delivered) made in polyethylene terephthalate (PET) and using carbon dioxide as the propellant. Without being bound by theory, carbon dioxide is able to slowly permeate through the minimally permeable PET layer of the flexible container, and to dissolve in the solution therein contained. The solution thus becomes progressively more stable, the stabilising effect being due, at least in part, to the free radical scavenging ability of dissolved inorganic carbon (which generally includes carbonates, bicarbonates, carbonic acid and dissolved CO2) to thereby slow down the decomposition of the hypohalous acid.
If the solution inserted in the internal flexible container has originally an alkaline pH, a larger amount of carbon dioxide will be required to stabilise the hypohalous acid. However, the pH of the solution can also be reduced prior to packaging by adding acid, as previously discussed. In such a case, the diffusion of carbon dioxide through the PET layer of the flexible container will take place anyway, thus providing the stabilising effect.
While the hypohalous acid solution may be in the form of a liquid, the solution may take the form of a cream, gel (e.g. silicate-based gel), and/or foam by the addition of conventional ingredients known in the art. For example, topical formulations of electrochemical solutions are disclosed in US 2005/0196462, which is hereby
incorporated by reference in its entirety. In these embodiments, the formulation is better contained around the application site by limiting solution run-off. Further, convenient applicators for creams, foams, and the like are known, and may be used in accordance with the present invention. Since the solutions of the invention provide the potential for low conductivity, even with relatively high AFC content, and at “skin- friendly” pH levels, the solutions of the invention are particularly suitable for hydrogel formulations.
In certain embodiments employing hydrogel formulations, the composition has an AFC content of greater than about 150 ppm, greater than about 200 ppm, greater than about 250 ppm, greater than about 300 ppm, or greater than about 400 ppm. Further, the formulation may have a conductivity of from about 0.3 mS/cm to about 12 mS/cm, such as from about 0.5 mS/cm to about 10 mS/cm in some embodiments. Further, hydrogel formulations in some embodiments have a pH of from about 5 to about 7, or from about 6 to about 6.5 in other embodiments. The hydrogels may be prepared from silicate- based carriers, such as sodium magnesium fluorosilicate (e.g., from about 0.5% to about 5%), and may employ an additional buffer for targeting the pH. An exemplary buffer is phosphoric acid.
The hypohalous acid solution of the invention may also be hypertonic, hypotonic, or isotonic with respect to physiological fluids (blood, plasma, tears, etc.). Alternatively, the solution may contain varying levels of salinity, such as from 0.01 to about 2.0%. Generally, the solution contains from about 0.02% to about 0.9% w/v NaCI when intended for use in medicine. In some embodiments, the solution may be a normal saline solution (about 0.91% w/v NaCI). In some embodiments, the solution may contain from about 0.01 to 2.0% w/v of one or more salts, such as a halide salt, e.g. NaCI, KCI, or a mixture of salts or halide salts. The salt or halide salt may be a salt of an alkali metal or alkaline earth metal, such as sodium, potassium, calcium, or magnesium. In certain embodiments, the electrolysed solution is generated using a mixture of physiologically balanced salts, as disclosed in U.S. Patent 6,426,066, which is hereby incorporated by reference in its entirety. Such salts may include potassium halides (e.g., KCI) and magnesium halides (e.g., MgCh).
Still other aspects of the invention provide methods of disinfecting or cleansing a mammalian tissue, such as a wound or burn, or disinfecting or cleansing a hard
surface, or for treating or preserving a food product or cut flowers. Due to the stability of the hypohalous acid solutions, such methods need not be performed proximately to the production of the biocidal solution, and the solution may be prepared well in advance of its use.
The solutions and formulations of the invention may be used as sterilising, disinfecting and biocidal solutions for human and animal care. The solutions are non-hazardous, non-irritating, non-sensitising to the skin, non-irritating to the eyes, not harmful if swallowed, and show no evidence of mutagenic activity. For example, the method of the invention provides for moistening, lubricating, irrigating, cleaning, deodorising, disinfecting, or debriding a wound by rinsing, washing or immersing the wound, with or in, the stabilised hypohalous acid solutions, or by applying the solution to the wound and/or wound dressing. The wound may or may not be infected, and thus the method of the invention is useful for treating infected wounds and useful for preventing infection of uninfected wounds.
In one aspect, the invention provides a convenient means for wound care and management and may be used in combination with the apparatus and methods described in U.S. 2010/030132, which is hereby incorporated by reference in its entirety. For example, the method may comprise supplying the stabilised solution to a wound site by one or more of soak, scrub, pulsed lavage, hydrosurgery, and ultrasound to effectively debride and disinfect a wound or tissue. The solution may be delivered before, during and/or after negative pressure wound therapy to promote proper wound healing physiology. In these embodiments, the method may employ a wound dressing for coordinating debridement by infusion of hypochlorous acid with negative pressure therapy. Thus, the invention may be used in combination with a wound treatment apparatus and/or wound dressing.
For example, in certain embodiments, the invention allows for an initial stabilised hypochlorous acid solution soak and/or scrub to both debride and disinfect the wound or tissue, followed by the application of negative pressure to the wound or tissue using the stabilised hypochlorous acid solution as an irrigating agent to control wound bioburden, remove excess exudate, and promote formation of granulation tissue. Optionally, the method also involves seamless transition to the stabilised hypohalous acid solution infusion (e.g., active or passive infusion without negative pressure). Such
seamless transition can be effected via a wound dressing which allows for controlled infusion of stabilised hypochlorous acid solution with controlled vacuum source. In these embodiments, continued cell proliferation and regeneration continues without disruption of the wound bed, once the endpoints of negative pressure therapy have been obtained.
In certain embodiments of the invention, the wound needing care is a stage l-IV pressure ulcer, stasis ulcer, diabetic ulcer, post-surgical wound, burn, cut, abrasion, or a minor irritation of the skin. In certain embodiments, the wound is rinsed, washed, or immersed in the solution periodically over at least two weeks, but treatment may continue periodically for over about 4 weeks, about 9 weeks, or more. The wound, in some embodiments, is rinsed with the solution at least once a week, but may be treated with the solution at least twice a week, or more frequently.
In some embodiments, the invention provides a method for treating an infected or colonised wound, tissue, surgical cavity, or bone, and a method for reducing wound bioburden. The treatment solution in accordance with the invention, as already described, is generally effective for killing or inactivating a broad spectrum of bacterial, fungal, and viral pathogens, including S. aureus, P. aeruginosa, E. coli, Enterococcus spp., C. difficile, and Candida spp.. The solution does not produce resistant species, making the methods desirable over the delivery of traditional antibiotics.
In another aspect, the solution of the invention is particularly suitable for use in conjunction with stem cell and growth factor therapy, including the use of genetically engineered cells and engineered tissue and allografts and organs for transplant in various treatments. Using the stabilised hypohalous acid solution of the invention to disinfect tissue before, during or after addition of cells or growth factors, maintains the viability of the cells and integrity of the growth factors, while killing the unwanted microbes.
In certain embodiments, the solution or formulation thereof is applied for the control of inflammation, including an inflammatory reaction or hyper-inflammation of the skin. For example, the solution or formulation thereof may be applied for use in a method as described in U.S. 2007/0196357 or U.S. 2010/0285151, which are hereby incorporated by reference. In certain embodiments, the solution or composition of the invention is
applied (e.g., to an affected area) for treatment of a patient having a dermatosis, atopic dermatitis, skin allergy, rosacea, psoriasis, or acne, among others. In such embodiments, the solution may be formulated as a hydrogel, for example, as described elsewhere herein.
In certain embodiments, this invention is advantageously used against microbes on surfaces because of its fast activity against bacterial spores, fungi, and other resistant microorganisms. Because of its effectiveness and the speed at which it acts, the invention meets a substantial public health need, and one that is not adequately addressed by current commonly used antimicrobial agents. Accordingly, application of the solution to various surfaces and materials is useful to control microbial contamination, not only for the care and management of wounds, but for disinfecting hard surfaces such as medical or dental equipment, preserving and decontaminating food products, water treatment, as well as other industrial and agricultural applications. In certain embodiments, the solution or composition of the invention is applied to crops (pre- or post-harvest) or cut flowers for their preservation and/or for improving the overall quality of the product. In some embodiments, the solution is potassium based and has one or more utilities (e.g., methods of use) as disclosed in PCT/US2011/43590, which is hereby incorporated by reference in its entirety.
Killing, inactivating, or otherwise reducing the active population of bacterial spores and fungi on surfaces is particularly difficult. Bacterial spores have a unique chemical composition of spore layers that make them more resistant than vegetative bacteria to the antimicrobial effects of chemical and physical agents. Likewise, the unique chemical composition of fungal cells, especially mould spores, makes them more resistant to chemical and physical agents than other microorganisms. This resistance can be particularly troublesome when the spores or fungi are located on surfaces such as food, food contact sites, ware, hospitals and veterinary facilities, surgical implements, and hospital and surgical linens and garments.
Control of the mould Chaetomium funicola, and of bacterial spore-forming microorganisms of the Bacillus species, can be especially important during food packaging, particularly during cold or hot aseptic filling of food and beverage products.
Microorganisms of the Bacillus species include Bacillus cereus, Bacillus mycoides, Bacillus subtilis, Bacillus anthracis, and Bacillus thuringiensis. These latter microorganisms share many phenotypical properties, have a high level of chromosomal sequence similarity, and are known enterotoxin producers. Bacillus cereus is one of the most problematic because it has been identified as possessing increased resistance to germicidal chemicals used to decontaminate environmental surfaces.
As used herein, the term “surface” refers to both hard and soft surfaces and includes, but are not limited to, tile grout, plaster, drywall, ceramic, cement, clay, bricks, stucco, plastic, wallpaper, fabric, tiles, cement and vinyl flooring, heating and/or cooling fins, filters, vanes, baffles, vents, crevices in walls or ceilings, paper and wood products such as lumber, paper, and cardboard, woven products such as blankets, clothing, carpets, drapery and the like. The term surface also includes human surfaces, animal surfaces, military equipment, transportation equipment, children’s items, plant surfaces, seeds, outdoor surfaces, soft surfaces, air, wounds, and medical instruments, and the like.
EXAMPLES
Example 1 : Solutions of free chlorine packaged using nitrogen aas as the propellant
Figures 3A and 3B show averages of three AFC and pH measurements for aqueous solutions of free chlorine (AFC * 380 ppm, initial pH » 9.8) produced by electrochemical treatment of a diluted saline, pH-adjusted to about 7 with hydrochloric acid. Different double-compartment packaging of the type used to deliver fluids under pressure were filled with aliquots of the same solution, stored at 40°C to accelerate the deterioration of the solution, and kept unopened until measurement. The solution should be stored at 25°C or at 20°C or less for greater stability; however, for stability testing, accelerated tests can be performed by storing the solution at a higher temperature, and the shelf- life predicted from accelerated data by extrapolation. For example, storing the solution at 15 °C above normal storage conditions (storage conditions for Australia are considered to be the temperatures of 25 - 30 °C), a time period of 3 months gives a
possible shelf-life prediction of 18 months (TGA instructions for disinfectant testing, version 2.1, March 2020 - Australian Government, Department of Health, Therapeutic Goods Administration). Aluminium cans and flexible PET pouches equipped with an aluminium mounting cap and a valve were used; nitrogen gas was used as the propellant. Although the AFC content remained relatively stable over time, showing a reduction of about 50% in just over two months, the pH of the solution dropped sharply in less than a month, becoming even more acidic in the long run.
Example 2: Stabilised solutions of free chlorine packaged using gaseous carbon dioxide as the propellant
In an attempt to stabilise the solution, an aqueous solution of free chlorine (AFC * 380 ppm, initial pH » 9.8) was produced by electrochemical treatment of a diluted saline and then pH-adjusted to about 7 with hydrochloric acid. Different double-compartment packaging of the type used to deliver fluids under pressure were filled with aliquots of the same solution, stored at 40°C to accelerate the deterioration of the solution, and kept unopened until measurement. Aluminium cans and flexible PET pouches equipped with an aluminium mounting cap and a valve were used; however, this time gaseous carbon dioxide was used as the propellant.
Figures 4A and 4B show averages of three AFC and pH measurements as a function of time; also shown is the non-linear regression (solid line) with 95% prediction intervals (broken lines). The results clearly show how solutions packaged in double compartment packaging of the type used to deliver fluids under pressure are more stable over time when pressurised with carbon dioxide, not only as regards their AFC content (more than 80 days were required to see a 50% reduction) but above all as regards the change in pH. This surprising result is attributable to the propellant, which appears to be able to slowly permeate through the minimally permeable PET layer of the flexible PET pouch, and to dissolve in the solution therein contained. The solution thus becomes progressively more stable, the stabilising effect being due, at least in part, to the free radical scavenging ability of dissolved inorganic carbon (which generally includes carbonates, bicarbonates, carbonic acid and dissolved CO2) to thereby slow down the decomposition of the hypohalous acid.
All references cited herein are incorporated by reference in their entireties.
Claims
1. A stabilised solution or formulation of an antimicrobial solution packaged in a double-compartment packaging comprising a flexible container of variable volume therein enclosing the stabilised solution or formulation, said flexible container of variable volume being inserted in a pressure-resisting external container, and comprising a pressurised propellant that is capable of exerting pressure on said flexible container of variable volume and forcing said stabilised solution or formulation out of said flexible container of variable volume upon pressing an actuator that is operatively connected to an ejection valve, wherein the solution or formulation has an available free halide (AFC) content of from 10 to 10,000 parts per million, and a pH of from 3.0 to 7.0, and wherein the pressurised propellant is carbon dioxide.
2. The stabilised solution or formulation packaged in a double-compartment packaging of claim 1, wherein the antimicrobial solutions is hypohalous acid.
3. The stabilised solution or formulation packaged in a double-compartment packaging of claim 1 or 2, wherein the hypohalous acid is hypochlorous acid.
4. The stabilised solution or formulation packaged in a double-compartment packaging of any one of claims 1 to 3, wherein said AFC content and said pH are stable for at least 6 months or at least one year.
5. The stabilised solution or formulation packaged in a double-compartment packaging of any one of claims 1 to 4, wherein said AFC content is from 100 to
1 ,000 parts per million, from 100 to 500 parts per million, or from 400 to 1,000 parts per million.
6. The stabilised solution or formulation packaged in a double-compartment packaging of any one of claims 1 to 5, wherein the flexible container of variable volume enclosing the stabilised solution or formulation is made of polyethylene terephthalate (PET).
7. The stabilised solution or formulation packaged in a double-compartment packaging of any one of claims 1 to 6, wherein the pressure-resisting external container is capable of resisting pressures in excess of 8 bars.
8. The stabilised solution or formulation packaged in a double-compartment packaging of any one of claims 1 to 7, wherein said AFC is prepared by electrolysis of a NaCI solution.
9. The stabilised solution or formulation packaged in a double-compartment packaging of any one of claims 1 to 8, wherein said solution or formulation has a salinity from 0.01 to 2.0%.
10. The stabilised solution or formulation packaged in a double-compartment packaging of any one of claims 1 to 9, wherein said solution or formulation is formulated as a gel, cream, or foam.
11. The stabilised solution or formulation packaged in a double-compartment packaging of claim 10, wherein the gel is a fluorosilicate hydrogel.
12. A method for disinfecting or treating a mammalian tissue, the method comprising applying the solution or formulation according to any one of claims 1 to 11 to a mammalian tissue in need of disinfection or treatment.
13. The method of claim 12, wherein the mammalian tissue is infected or optionally comprises a wound or burn.
14. The method of claim 13, wherein the stabilised solution or formulation is applied to an affected area of a mammal having one or more dermatoses or a mammal having atopic dermatitis.
15. A method for disinfecting or cleansing a hard surface comprising applying the stabilised solution or formulation of any one of claims 1 to 11 to the hard surface, and optionally, wherein the hard surface comprises porcelain, glass, steel, iron, ceramic or polymeric material.
16. A method of treating a food product comprising applying the stabilised solution or formulation of any one of claims 1 to 11 to the food product, and optionally, wherein the solution is applied as a mist, fog, spray, or ice.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2021901932A AU2021901932A0 (en) | 2021-06-25 | Fluid Delivery Device | |
PCT/AU2022/050438 WO2022266697A1 (en) | 2021-06-25 | 2022-05-10 | Fluid delivery device |
Publications (1)
Publication Number | Publication Date |
---|---|
EP4358719A1 true EP4358719A1 (en) | 2024-05-01 |
Family
ID=84543764
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP22826873.6A Pending EP4358719A1 (en) | 2021-06-25 | 2022-05-10 | Fluid delivery device |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP4358719A1 (en) |
AU (1) | AU2022300030A1 (en) |
WO (1) | WO2022266697A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE546097C2 (en) * | 2023-01-20 | 2024-05-21 | Bactiguard Ab | An antimicrobial gel composition comprising sodium hypochlorite and having a ph of 8-10 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4090579B2 (en) * | 1998-07-14 | 2008-05-28 | 東洋エアゾール工業株式会社 | Method for manufacturing double aerosol container and double aerosol container formed by this manufacturing method |
PL1851135T5 (en) * | 2005-02-15 | 2015-12-31 | Power Container Corp | Device for delivering fluids, especially pressurised medicating fluids |
CN1854081A (en) * | 2005-04-28 | 2006-11-01 | 株式会社Osg | Preparation of additive solution for electrolytic disinfecting liquid containing hypochlorite |
US20090148342A1 (en) * | 2007-10-29 | 2009-06-11 | Bromberg Steven E | Hypochlorite Technology |
-
2022
- 2022-05-10 AU AU2022300030A patent/AU2022300030A1/en active Pending
- 2022-05-10 WO PCT/AU2022/050438 patent/WO2022266697A1/en active Application Filing
- 2022-05-10 EP EP22826873.6A patent/EP4358719A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
AU2022300030A1 (en) | 2024-01-25 |
WO2022266697A1 (en) | 2022-12-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10576152B2 (en) | Stabilized hypohalous acid solutions | |
US9925217B2 (en) | Methods for treating inflammation associated with allergic reaction | |
US20140328945A1 (en) | METHOD FOR STABILIZING AN ELECTROCHEMICALLY GENERATED SANITIZING SOLUTION HAVING A PREDETERMINED LEVEL OF FREE AVAILABLE CHLORINE AND pH | |
CA2829449A1 (en) | A stable composition of hoci, processes for its production and uses thereof | |
US20150044144A1 (en) | Disinfectant solution | |
EP1648523B1 (en) | Sterilant system | |
EP4358719A1 (en) | Fluid delivery device | |
US11452778B2 (en) | Stabilized hypohalous acid solutions | |
EP4358720A1 (en) | Delivery device for a stabilised hypohalous acid solution | |
EP4358977A1 (en) | Stabilised hypohalous acid solutions | |
AU2020439009A1 (en) | Disinfectant Dispenser and Method of Construction | |
JP2022026914A (en) | Antibacterial agent for viruses |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
17P | Request for examination filed |
Effective date: 20240111 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |